October 13, 2026 Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai 400 001 Listing Department National Stock Exchange of ‘Exchange Plaza’ Bandra-Kurla Complex Bandra (East), Mumbai 400 051 India Limited Dear Sir/Madam,…
October 13, 2026
Listing Department
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street,
Mumbai 400 001
Listing Department
National Stock Exchange of
‘Exchange Plaza’
Bandra-Kurla Complex
Bandra (East), Mumbai 400 051
India
Limited
Dear Sir/Madam,
Scrip Code: Equity (BSE: 540133/NSE: ICICIPRULI) Debt (NSE: ICPR34, ICPR35)
Subject: Outcome of the Board Meeting held on October 13, 2026
The Board of Directors (the Board) of ICICI Life Insurance Limited at their meeting, which
commenced at 11:05 a.m. and concluded at 1:07 p.m. on Tuesday, October 13, 2026, inter alia,
approved the Un-audited financial statements and financial results (standalone) for the quarter
and half year ended September 30, 2026.
Pursuant to Regulation 33, Regulation 52 and other applicable provisions of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), a copy of the
un-audited financial results (standalone) for the quarter and half year ended September 30, 2026,
the limited review reports issued by M. P. Chitale & Co. and Chaturvedi & Co LLP, the joint statutory
auditors in the prescribed format, along with a copy of press release are enclosed.
Further, as per the Regulation 23(9) of the Listing Regulations, the listed entity shall submit to the
stock exchanges, the disclosures of related party transactions in the prescribed format. Please be
informed that said disclosures shall also be filed in prescribed XBRL format, as a part of Integrated
Filing (Financial) simultaneously.
In continuation to the intimation dated October 2, 2026, upon appointment as an Additional
Director effective October 14, 2026, Mr. Sidharatha Mishra shall cease to be a Senior Management
Personnel, from the said date.
The disclosures as per Regulation 30 and 51 alongwith the details as required under Para A (7) of
Part A of Schedule III of Listing Regulations read with SEBI Master Circular dated January 30, 2026
are enclosed herewith as Annexure I.
Kindly take the above information on records.
Thanking you,
Yours sincerely,
For ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
signed by NAIR
NAIR PRIYA Digitally
PRIYA SRIKUMAR
Date: 2026.10.13
SRIKUMAR 13:13:08 +05'30'
Priya Nair
Company Secretary
ACS 17769
Encl.: As above
CC: Axis Trustee Services Limited, Debenture Trustee
ICICI Life Insurance Limited
(Formerly known as: ICICI Prudential Life Insurance Company Limited)
Regd. Office: ICICI Prulife Towers, 1089, Appasaheb Marathe Marg, Prabhadevi, Mumbai
Annexure I
Sr.
No.
Particulars
Description
Reasons for change viz. appointment,
re-appointment, resignation, removal,
death or otherwise
Upon appointment as an Additional Director
effective October 14, 2026, Mr. Sidharatha
Mishra shall cease to be a Senior
Management Personnel, from the said date.
Date
of
appointment/reappointment/cessation (as applicable)
and
term
of
appointment/reappointment
Brief Profile (in case of appointment)
Please refer Point no. 1 above.
Disclosure of relationships between
Directors (in case of appointment of a
director)
Not applicable
Not applicable
ICICI Life Insurance Limited
(Formerly known as: ICICI Prudential Life Insurance Company Limited)
Regd. Office: ICICI Prulife Towers, 1089, Appasaheb Marathe Marg, Prabhadevi, Mumbai
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Statement of Standalone Unaudited Results for the quarter and half year ended September 30, 2026
(fin Lakhs)
Three months ended/at
September 30,
June 30,
September 30,
2026
2026
2025
(Unaudited)
(Unaudited)
(Unaudited)
Sr
Particulars
No.
Six months ended/at
September 30, September 30,
2026
2025
(Unaudited)
(Unaudited)
Year ended/at
March 31,
2026
{Audited)
POLICYHOLDERS' ACCOUNT
Gross premium income
1
(o) First Year Premium
214,570
729,647
(b} Renewal Premium
171,186
538,360
315,517
197,517
685,178
347,008
385,756
1.268,007
796,759
342,059
1,179,343
603,705
843,223
2,831,556
1,637,685
974,933
1.850,024
9,360
1.184,310
(22,667)
5,792
2,034,629
1,642,192
11,034
45,724
5,133,563
1,086,515
22,987
98,973
le) Single Premium
2 Net oremium income 1
3 Income from investments: lNetl 2
4 Other income
5 Transfer of funds from Shareholders' A/c
481.242
1,380,390
34,129
6
1,174,265
5,173
2,839,490
2,355,323
1,637,695
15,985
4,752
1,201,564
4,013,755
3,733,579
6,342,038
51,886
14,736
70,933
30,423
10,364
60,629
47,562
15,189
57,625
82,309
25,100
131,562
80,443
25,984
108,384
210,985
60,097
247,025
137,555
101,416
120,376
238,971
214,811
518,107
55,108
72,754
51,171
70,161
46,447
48,361
106,279
142,915
95,312
94,170
187,900
254,711
265,417
222,748
215,184
488,165
404,293
960,718
570
641
2,041
1,211
2.489
5,821
(1,614)
896
1,045
1,045
845
3,845
3,845
15,427
4,682
1,741
4,890
4,890
32,108
9,358
9,358
Benefits Paid 4 (Net) 1
Change in actuarial liability
1,292,389
(405,023)
894,985
1,668,814
1,127,681
(211,943)
2,187,374
1,263,791
2,103,919
1,095,296
Total (10+11+12+13+14+15+16)
1,155,294
2,791,878
1,153,072
3,947,172
3,647,463
4,719,880
402,744
6,095,828
18,971
47,612
48,492
66,583
86,116
246,210
13,100
5,871
24,504
23,108
42,032
6,460
37,604
28,979
69,093
17,023
180,520
65,690
22,098
19,937
21.305
42,035
98,670
18,971
47,612
48,492
66,583
37,541
86,116
246,210
41,069
67,549
69,797
108,618
123,657
412,539
13,100
24,504
42,032
37,604
69,093
180,520
{a) Investment Income
35,073
61,387
3,303
10,888
4,752
56,674
41
10.386
45,724
126,588
197
5,259
(421)
26,314
3,106
5,629
5,173
31,833
(b) Other income
513
99
19,893
98,973
28
7,638
43,122
4,504
34,701
86,654
69,185
180,675
4,504
4,775
4,775
10,614
10,614
9,050
9,050
20,639
20,639
37,422
29,926
76,040
60,135
160,036
37,422
38,618
29,926
76,040
60,135
160,036
1212,329)
6,625
(421)
Total (2 to 5)
Commission on
7
8
9
{a) First Year Premium
(b) Renewal Premium
{c) Singh:! Premium
Net Commission 3
Operatinq Expenses related to insurance business
(a} Employees remuneration and welfare expenses
{b} Other operating expenses
10 Expenses of Management (8+9)
11 Provisions for doubtful debts (including bad debts written off)
12 Provisions for/(revcrsal of) diminution in value of investments
13 Goods and Services tax on UUP chdrges
Provision for taxes {a+b)
14
(a) Current tax (credit)/charge
4,682
33,575
125.296)
(25,296)
lb) Deferred tax (credit)/charge
15
16
17
18
Surplus/(Deficit) (6-17)
Appropriations
19
{a) Transferred to Shareholders
(b/ Funds for Future Appropriations
Details of Surplus/(Deficit)
20
(a) Interim and other bonuses paid
(b) Allocation of bonus to policyholders
(c) Surplus shown in the Revenue Account
Total Surplus
67,659
SHAREHOLDERS'ACCOUNT
21 Transfer from Policyholders' Account
Total income under Shareholders' Account
22
23
24
25
26
27
28
Expenses other than those related to insurance business
Transfer of funds to Policyholders A/c
22
5,057
34,129
Provisions for doubtful debts {including write off)
Provisions for diminution in value of investments
Profit/(loss) before tax
Provisions for tax {a ➔ b)
43,532
6,110
6,110
{a) Current tax (credit)/chorge
{b) Deferred tax (credlt)/chor9e
29 Profit/(loss) after tax and before extraordinary items
30 Extraordinary Items (Net of tax expenses)
31 Profit/(loss) after tax and extraordinary items
Dividend per share (f) {Nominal Value f 10 per share}:
32
{a) Interim Dividend
(bl Final Dividend
33 Profit/(Loss) carried to Balance Sheet
34 Paid up equity share capital
35 Reserve & Surplus {excluding Revaluation Reserve)
36 Fair value Change Account and revaluation reserve
Total Assets:
867,633
145,123
1,278,566
39,639
830,211
145,078
1,238,998
53,422
715,626
144,677
1,106,910
21,138
867,633
145,123
1,278,566
39,639
715,627
144,677
1,106,910
21,138
1.65
815,528
144,928
1,218,184
(167)
1,644,753
14,761,149
15,848,413
431,912
1,632,197
14,583,206
16,541,489
409,354
1,583,411
13,440,521
16,557,342
450,447
1,644,753
14,761,149
15,848,413
431,912
1,583,411
13,440,521
16,557,342
450.447
1,572,759
14,129,952
15,105,238
464,573
(a) Investments:
37
- Shareholders'
- Policyholders Fund excluding Linked Assets
- Assets held to cover Linked Liabilities
(b) Other Assets (Net of current liabilities and provisions)
Foot Notes:
1 Net of reinsurance
2 Net of amortisation and losses (including capital gains}
3 Inclusive of rewards and/or remuneration to agents. brokers or other intermediaries
4 Inclusive of interim and other bonuses
/;. I z.e :,,....
(p'-mL-'•i1i"
c:,a·,.__'f.Al.srt.'
Cl: MUMBAI g
~
•
*.
-o-~
Ci)
;,,.,
~c
~~
-~,§
r>
• 4111 ~
~:.Dl&c.
I
~
o<-
~ FRN 302137El ~
U
E300286
~
MUMBAI
If:
~
~f
lreor,,,cc
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Standalone Balance Sheet at September 30, 2026
('f in Lakhs)
Particulars
At September 30,
At June 30,
At March 31,
At September 30,
2026
2026
2026
2025
(Unaudited)
(Unaudited)
(Audited)
(Unaudited)
Sources of funds
Shareholders' funds:
Share capital
Share application money
Reserve and surplus
145,123
1,291,502
26,703
1,463,328
145,078
23
1,251,934
40,486
144,928
170
1,231,120
(13,103)
1,110,939
17,109
1,437,521
1,363,115
1,272,725
259,500
259,500
259,500
260,000
210,941
5,347
317,616
5,347
190,219
5,347
396,349
4,422
Policy liabilities
Insurance Reserve
14,675,711
14,387,657
14,155,095
13,395,542
Provision for linked liabilities (fund reserves) (A)
(a) Provision for linked liabilities
(b) Credit/[Debit] fair value change account (Linked)
15,228,196
13,506,153
1,722,043
15,922,490
13,322,778
2,599,712
14,527,436
13,181,446
1,345,990
15,949,012
12,826,205
3,122,807
Funds for discontinued policies (BJ
(a) Discontinued on account of non-payment of premium
(b) Other discontinuance
(c) Credit/[debit] fair value change account
Total linked liabilities (A)+(B)
Sub - total
620,217
619,897
320
618,999
618,649
350
577,802
577,458
344
Credit/[Debit] fair value change account
Sub -total
Borrowings
Policyholders' funds:
Credit/[Debit] fair value change account
Revaluation reserve - Investment property
Funds for Future Appropriations
Linked
Non linked
Sub -total
Total
Application of funds
Investments
Shareholders'
Policyholders'
Asset held to cover linked liabilities
Loans
Fixed assets - net block
Current assets
Cash and Bank balances
Advances and Other assets
Sub-Total (A)
Current liabilities
Provisions
Sub-Total (B)
Net Current Assets (C) = (A-BJ
Miscellaneous expenditure (to the extent not written-off or adjusted)
Debit Balance in Profit & Loss Account (Shareholders' account)
Total
Contingent liabilities
144,677
15,848,413
30,740,412
16,541,489
31,252,109
15,105,238
29,455,899
608,330
607,539
376
415
16,557,342
30,353,655
4,247
218,740
222,987
32,686,227
3,789
213,327
217,116
33,166,246
3,188
190,820
194,008
31,272,522
2,399
142,942
145,341
32,031,721
1,644,753
14,761,149
15,848,413
321,666
71,540
1,632,197
14,583,206
16,541,489
312,549
72,001
1,572,759
14,129,952
15,105,238
300,623
71,100
1,583,411
13,440,521
16,557,342
272,662
15,311
596,554
611,865
13,758
627,086
640,844
113,770
680,051
793,821
13,719
500,867
514,586
568,643
4,516
573,159
38,706
611,263
4,777
616,040
24,804
696,631
4,340
700,971
92,850
416,440
3,432
419,872
94,714
32,686,227
76,823
33,166,246
82,043
31,272,522
82,644
83,071
32,031,721
106,189
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Segment1 Reporting (Standalone) for the quarter and half year ended September 30. 2026
(" in Lakhs)
Three months ended/at
Sr
No.
1
Particulars
September 30,
2026
(Unaudited)
June 30,
2026
(Unaudited)
September 30,
2025
(Unaudited)
Six months ended/at
September 30,
September 30,
2026
2025
(Unaudited}
(Unaudited}
Year ended/at
March 31,
2026
(Audited)
Segment Income:
Segment A! Par life
Net Premium
140,160
83,900
216.796
542.186
86,167
68,963
137.905
82,151
224.060
Income fTom investments 2
150,366
155,130
3,550
6,336
3,198
9,886
6,182
296,053
121
12,787
Net Premium
11,395
5,848
6,834
17,243
11,680
46,484
Income from investments 2
2,961
2,815
2,633
5,776
5,764
Transfer of Funds from shareholders' account
Other income
Segment B: Par pension
11,055
29
14
13
3
27
4
13
Net Premium
489,843
358,109
342,951
847,952
640,996
1,731,323
Income from investments 2
124,230
(3,958)
2,804
161,222
5.173
2,791
132,047
33,968
2,445
285,452
1,215
5,595
275,044
45.501
4,588
539,381
76,831
9,566
Net Premium
6.704
12,282
5,178
18.986
8,893
78,995
Income from investments 2
Transfer of Funds from shareholders' account
3,899
3
3,742
3,097
7,641
3
7,286
13,526
Transfer of Funds from shareholders' account
Other income
Segment C: Non Par Life
Transfer of Funds from shareholders' account
Other income
Segment D: Non Par Pension
Other income
7
Segment E: Non Par Variable Life
4
3
6
(4)
33
56
42
58
Net Premium
Income from investments 2
Transfer of Funds from shareholders' account
7
Other income
Segment F: Non Par Variable Pension
Net Premium
41
36
41
127
359
Income from investments 2
22
29
67
129
33
(2)
51
Tran sfer of Funds from shareholders' account
Other income
Segment G: Annuity Non Par
Net Premium
78,369
50.040
62.598
128,409
114.069
264,158
Income from investments 2
33,756
3,443
187
34,155
27,266
59,790
150
82
67,911
3,443
337
141
119,003
21,249
321
Net Premium
797
636
707
1,433
1,395
2,936
Income from investments 2
Transfer of Funds from shareholders' account
238
236
82
474
333
1
1
1
1
818
1
2
Transfer of Funds from shareholders' account
Other income
Segment H: Health Non Par
Other income
Segment I: Linked Life
Net Premium
500,489
390,409
481.490
890,898
839,967
1,961,303
Income from investments 2
Transfer of Funds from shareholders' account
(434,339)
1,448,755
(262,438)
1,014,416
1.045.775
69
62
139
117
60.256
454
275
Other income
70
Segment J: Linked Pension
Net Premium
Income from investments 2
6,080
4,138
4,582
10,218
6,903
19,068
(14,119)
50,686
(9,851)
36,567
42,067
9,436
8
(131)
(384)
8,667
(339)
8,570
6
2,229
1
Transfer of Funds from shareholders' account
Other income
Segment K: Linked Health
Net Premium
Income from investments 2
Transfer of Funds from shareholders' account
(157)
(2,564)
(227)
11,231
(1,699)
Other income
Segment L: Linked Group Life
Net Premium
135,002
49,920
133,302
184,922
173,877
431,461
Income from investments 2
(10.156)
91
49,765
2,319
167
1
39,609
91
30,744
167
1
22,514
221
15
Transfer of Funds from shareholders' account
Other income
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited}
Segment 1 Reporting (Standalone} for the quarter and half year ended September 30, 2026
(:tin Lakhs)
s,
No.
Three months ended/at
Particulars
September 30,
June 30,
2026
2026
(Unaudited)·
(Unaudited}
September 30,
2025
(Unaudited}
Six months ended/at
September 30,
September.30,
2026
(Unaudited}
2025
(Unaudited)
Year ended/at
March 31,
2026
(Audited)
Segment M: Linked Group Pension
Net Premium
11,708
19,837
8,858
31,545
20,265
Income from investments 2
(2,428)
18,422
1,687
15,994
16,353
Transfer of Funds from shareholders' account
Other income
55,284
13,687
1
Shareholders
Income from investments2
35,073
197
26,314
3,106
31,833
22
61,387
3,303
56,161
41
118,950
Segment A: Par life
6,000
22,533
6,173
28,533
17,372
84,357
Segment B: Par pension
(587)
Segment C: Non Par Life
Segment 0: Non Par Pension
3,958
(5,685)
315
13,400
1,125
1,048
(545)
416
23,901
(26)
(5,173)
51
7
2
2,242
413
19.406
1,629
745
454
156
19,287
(143)
(33,9681
(277)
4
8
1,990
48
39,330
(613)
(1,215)
(3)
8
2
(3.443)
728
32,806
(1,261)
(45,501)
757
(56)
6
15.780
894
47,404
(2,037)
(76,831)
918
(58)
10
(21,249)
3,059
148,056
1,646
2,754
3,840
7,008
81
(9171
388
22,023
1,793
(91)
572
43,188
686
(167)
638
36,766
2,927
(221)
4,100,405
180,665
8,388,638
216,207
200
1,016
2,065,117
13,916
13,761,055
512,060
129,021
1,170,770
424.329
1,722.828
4,092,615
172,008
8,299,008
208,206
197
1,959
2,002,819
13,654
14.474,374
540,861
134,258
1,098,342
430,924
1,697,021
4,043,774
142,710
7,555,843
164,284
426
2,007
1,818,483
14.606
14,705,783
584,115
4,100,405
180,665
8,388,638
216,207
200
1,016
2,065,117
13,916
13,761,055
512,060
3,996,354
166,996
8.091.158
203,672
207
1,932
1,944.421
13,578
13,145,627
502,255
136,316
129,021
912,920
417,729
1,532,724
1,170,770
424,329
1,722,828
4,043,774
142.710
7,555,843
164,284
426
2,007
1,818,483
14,606
14,705,783
584,115
136,316
912,920
417,729
1,532,724
4,100,405
180,665
8,388,638
216,207
200
1,016
2,065.117
13,916
13,761,055
512,060
129,021
1,170,770
424,329
4,092,615
172,008
8,299,008
208.206
197
1,959
2,002,819
13,654
14.474,374
540,861
134,258
1,098,342
430,924
4,043,774
142,710
7,555,843
164.284
426
2,007
1,818,483
14,606
14,705,783
584.115
136,316
912,920
417,729
4,100,405
180,665
8,388,638
216,207
200
1,016
2,065,117
13,916
13.761.055
512.060
129,021
1,170,770
424,329
4.043,774
142,710
7,555,843
164,284
426
2,007
3,996,354
166,996
8,091,158
203,672
207
1,932
1,818,483
1,944,421
14.606
14,705,783
584.115
136,316
912.920
417,729
13,578
13,145,627
502,255
125,401
1,046.998
411,308
Other income
2
Segment Surplus/(Deficit} (net of transfer from shareholders' A/c):
(54)
1
Segment E: Non Par Variable Life
Segment F: Non Par Variable Pension
Segment G: Annuity Non Par
Segment H: Health Non Par
Segment I: Linked Life
Segment J: Linked Pension
Segment K: Linked Health
Segment L: Linked Group Life
Segment M: Linked Group Pension
Shareholders
3
Segment B: Par pension
Segment C: Non Par Life
Segment D: Non Par Pension
Segment E: Non Par Variable Life
Segment F: Non Par Variable Pension
Segment G: Annuity Non Par
Segment H: Health Non Par
Segment I: Linked Life
Segment J: Linked Pension
Segment K: Linked Health
Segment L: Linked Group Life
Segment M: Linked Group Pension
Shareholders
125,401
1,046,998
411,308
1,622.615
Segment Policy Liabilities3 :
Segment A: Par life
Segment B: Par pension
Segment C: Non Par Life
Segment D: Non Par Pension
Segment E: Non Par Variable Life
Segment F: Non Par Variable Pension
Segment G: Annuity Non Par
Segment H: Health Non Par
Segment I: Linked Life
Segment J: Linked Pension
Segment K: Linked Health
Segment L: Linked Group Life
Segment M: Linked Group Pension
Footnotes:
1 Segments are as under:
(a) Linked Policies (i) Life (ii) General Annuity and Pension (iii} Health (iv) Variable
(b) Non-Linked
- Non-Participating Policies: (i) Life (ii) General Annuity and Pension {iii) Health (iv) Variable
- Participating Policies: (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable
2
3
1,298
78,489
Segment Assets:
Segment A: Par life
4
99
(c) Variable insurance shall be further segregated into Life and Pension
Net of provisions/(reversal) for diminution in value of investments.
Includes the fund for future appropriations, fair value change and revaluation reserve of investment property.
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Statement of Standalone Unaudited Results for the quarter and half year ended September 30, 2026
Three months ended/at
Sr
No.
September 30,
Particulars
June 30, 2026
2026
(Unaudited)
(Unaudited)
Six months ended/at
September
September 30,
Year ended/at
September 30,
30, 2025
2026
2025
(Unaudited)
(Unaudited)
(Unaudited)
March 31, 2026
(Audited)
Analytical Ratios: 1
(i)
(ii)
(iii)
(iv)
Solvency Ratio:
Expenses of management ratio
Policyholder's liabilities to shareholders' fund
229.9%
18.6%
2116.0%
225.4%
213.2%
229.9%
213.2%
21.8%
2189.1%
17.5%
2396.4%
19.9%
2116.0%
19.0%
2396.4%
227.3%
18.1%
2175.2%
2.58
2.66
2.07
5.24
4.16
11.06
2.57
2.66
2.06
5.23
4.13
11.00
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
7.8%
9.4%
7.7%
11.1%
8,6%
8.7%
7.2%
9.3%
8.1%
11.3%
8.5%
7.8%
10.5%
8.9%
3.1%
2.0%
13.0%
0.4%
(1.0%}
Earnings per share {'):
{a) Basic EPS before and after extraordinary items (net of tax expense)
for the period (not annualised except year end}
(b) Diluted EPS before and after extraordinary items (net of tax
expense) for the period (not annualised except year end)
NPA ratios: (for policyholders' fund)
(a) Gross & Net NPAs
(b) % of Gross & Net NPAs
(v)
(vi)
NIL
Yield on Investments (on policyholders' fund)
A. Without unrealised gains
- Non Linked Par
- Non linked Non Par
9.4%
7.0%
10.5%
7.4%
8.0%
B. With unrealised gains
- Non Linked Par
- Non Linked Non Par
- linked Non Par
(vii)
(3.9%)
(4.1%)
(12.1%)
23.5%
20.8%
(0.5%)
(0.8%)
47.0%
(7.7%)
8.9%
7.5%
13.7%
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
8.6%
(1.8%)
6.6%
29.0%
8.2%
1.1%
7.6%
12.5%
7.3%
9.7%
7.8%
5.5%
83.9%
83.4%
74.0%
81.4%
84.7%
82.8%
83.1%
76.5%
NPA ratios: (for shareholders' fund)
(a) Gross & Net NPAs
(b) % of Gross & Net NPAs
(viii) Yield on Investments {on Shareholders' Ale)
A. Without unrealised gains
8, With unrealised gains
(ix)
Persistency Ratio {Regular Premium/ Limited Premium Payment under
Individual category) 2
Premium Basis
13th month
25th month
74.5%
37th month
49th month
61st month
Number of Policy Basis
13th month
25th month
37th month
49th month
61st month
Conservation Ratio
Par Life
Par Pension
Non Par Life
Non Par Pension
Non Par Variable
Non Par Variable Pension
Annuity Non Par
Health
Linked Life
Linked Pension
Linked Health
Linked Group Life
Linked Group Pension
(x)
72.9%
70.7%
72.5%
69.9%
63.3%
62.3%
83.2%
82.7%
74.7%
67.0%
74.9%
67.6%
61.5%
61.7%
60.8%
60.3%
84.5%
76.2%
77.0%
78.5%
74.4%
70.6%
59.5%
75.0%
76.6%
71.6%
62.5%
70.7%
71.1%
62.6%
61.7%
79.9%
71.5%
64.8%
63.5%
54.6%
82.8%
74.8%
68.4%
62.7%
59.4%
81.8%
73.3%
65.8%
73.2%
67.1%
63.3%
62.8%
63.4%
57.7%
82.7%
86.1%
89.1%
NA
NA
NA
83.0%
79.8%
86.2%
NA
NA
NA
80.6%
70.1%
83.2%
93.1%
87.9%
NA
NA
NA
82.6%
61.2%
85.5%
151.9%
64.3%
101.8%
50.1%
111.9%
79.3%
80.7%
95.2%
99.8%
102.4%
96.3%
83.1%
97.0%
95.2%
101.2%
99.0%
78.7%
104.2%
79.5%
66.4%
96.6%
42.5%
118.5%
81.0%
86.2%
95.2%
100.1%
100.5%
82.1%
80.4%
67.9%
95.7%
41.6%
108.8%
84.0%
NA
NA
NA
88.4%
NA
NA
NA
81.8%
79.9%
91.6%
88.5%
NA
NA
NA
56.7%
86.0%
79.7%
75.5%
93.0%
51.1%
115.6%
Notes:
1 Analytical ratios have been calculated as per the definition given in IRDAI Analytical ratios disclosure.
2
Calculations are in accordance with the IRDAI circular IRDAI/NLJMSTCIR/RT/93/6/2024 dated June 14, 2024.
a} Persistency ratios for the quarter ended September 30, 2026 hove been calculated on September 30, 2026 for the policies issued in June to August period of the relevant years. For
example, the 13th month persistency for quarter ended September 30, 2026 is calculated for policies issued from June 1, 2025 to August 31, 2025
b) Persistency ratios for the quarter ended June 30, 2026 have been calculated on July 31, 2026 for the policies issued in April to June period of the relevant years. For example, the
13th month persistency for quarter ended June 30, 2026 is calculated for policies issued from April 1, 2025 to June 30, 2025.
c) Persistency ratios for the quarter ended September 30, 2025 have been calculated on October 31, 2025 for the policies issued in July to September period of the relevant years. For
example, the 13th month persistency for quarter ended September 30, 2025 is calculated for policies issued from July 1, 2024 to September 30, 2024.
d) Persistency ratios for the year ended September 30, 2026 have been calculated on September 30, 2026 for the policies issued in September to August period of the relevant years.
For example, the 13th month persistency for year ended September 30, 2026 is calculated for policies issued from September 1, 2024 to August 31, 2025
e) Persistency ratios for the year ended September 30, 2025 have been calculated on October 31, 2025 for the policies issued in October to September period of the relevant years. For
example, the 13th month persistency for year ended September 30, 2025 is calculated for policies issued from October 1 , 2023 to September 30, 2024.
f) Persistency ratios for the year ended March 31, 2026 have been calculated on April 30, 2026 for the policies issued in April to March period of the relevant years. For example, the
13th month persistency for year ended March 31, 2026 is calculated for policies issued from April 1, 2024 to March 31, 2025.
g) Group policies and policies under micro insurance products are excluded.
\ Lif
c,8\i.Al.~cf
°-: t11Ut-ABAI g
~ *c_r,...
~
(.;
~ "':i%> ~
1'\
-·lrKJ~~"'
*·
.c;, I
'° aC" Q
r.; "':'I
--0
-•....;:; ....'q?',;::,,
~¼n ';J'>
~'i,;.Dl&c,
J$>
0
~ FRN 302137 ~
~
E300286
Q
~
MUMBAI
&
~~
~li'C
JCJCI Life Insurance Limited (Formerly known as ICICI Prudential Life Insurance Company limited)
Unaudited Condensed Interim Standalone Receipts & Payments Account for the half year ended September 30, 2026
(~inlakhs)
Particulars
Half Year ended September 30, 2026
Year ended March 311 2026
Half Year ended September 30, 2025
(Unaudited)
(Audited}
(Unaudtted)
CASH FLOWS FROM OPERATING ACTIVITIES
Premium and other receipts (net of Goods and Services tax)
Fees & Charges
Interest received on tax refund
Payments to the re-insurers, net of commissions and claims
Payments to co-insurers, net of claims recovery
Payments of claims
2,520.242
38,875
5,928
(17,744)
5,431,969
46,364
2,235,154
29,557
(12,678)
{9,309)
(2,255,452)
(4,863,563)
(2,161,946)
Payments of commission and brokerage 1
(251,811)
(512,499)
(256,023)
Payments of other operating expenses 2
(279,504)
(469,377)
(254,193)
(1,891)
30,631
(41,282)
(3,108)
(58,835)
(92,983)
(2,137)
(22,045)
(65,265)
Preliminary and pre-operative expenses
Deposits, advances and staff loons
Income taxes paid (Net)
Goods and Services tax paid
Other payments
Cash flows before extraordinary items
Cash flow from extraordinary operations
(2,817,053)
(252,008)
Net cash flow from/ (used in) operating activities (A)
(6,013,043)
(534,710)
(252,008)
(534,710)
(2,770,918)
(506,207)
(506,207)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of fixed assets
Proceeds from sale of fixed assets
Purchase of investments
Capitol Infusion in subsidiary
Net cash inflow from disposal of subsidiary
Loans disbursed
Loans against policies
Proceeds from sole of investments
Repayments received
Advance/deposit for investment property
Interest, dividend & rent received (net of tax deducted at source)
Investments in money market instruments and in liquid mutual funds (Net)
Expenses related to investments
Net cashflow from/ {used in) investing activities {B)
(8,086)
30
(8,056)
(7,802.536)
(12,104)
95
(21,043)
7,605,532
695,312
(167,449)
(1,845)
299,915
(12,009)
(14,915,253)
(3,000)
20,350
(6,063)
221
(5,842)
(6.800,902)
(3,000)
(58,715)
14,261,230
(30,756)
7,021,538
379
1,197,959
268,823
(3,383)
756,381
610,650
(123,365)
(1,855)
666,468
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of share capita1 3
15,099
(387)
4,870
(17,304)
(31,772)
(17,060)
(12,306)
(7,436)
79
30,682
992,442
1.023,124
4
204.615
787,827
992,442
1
152,826
787,827
940,653
6,223
20,506
6,878
6,634
Proceeds from borrowing
Repayments of borrowing
Interest, Dividend paid
(23,938)
Net cashflow from/ {used in} financing activities (C)
Effect of foreign exchange rates on cash and cash equivalents (net} (D)
Net increase/(decrease) in cash and cash equivalents (A+B+C+D)
Cash and cash equivalents at beginning of the period/year
Cash and cash equivalents at end of the period/year
Note;
Cash and cash equivalents at the end of the period/year
- Cash (Including cheques in hand and stamps in hand)
- Bank Balances and Money at call and short notice 4
[Including bank balance for linked business of '{131 lokhs at September 30, 2026, '{ 737
lokhs at March 31, 2026, ~ 7 4 lakhs at September 30, 2025]
- Other short term liquid investment
[Forming part of Investments and Other Assets in Balance Sheet)
-Stamps on Hand
[Part of Cash (including cheques, drafts and stomps), however not o part of cash and
9,219
94,001
6,915
1,009,723
881,104
929,800
cash equivalents}
Cash and cash equivalents at end of the period/year
(2,041)
1,023,124
(3,169)
992,442
(2,940)
940,653
1,023,124
992,442
3.169
(737)
(881,104)
113,770
940,653
2,940
(74)
(929,800)
13,719
Reconciliation of Cash and cash equivalents with Cash and Bank Balance
Cash and cash equivalents
Add: Stamps on Hand
Less: Linked business bank balance
Less: Other short term liquid investment
Cash and Bank Balance
1
2.041
(131)
(1,009,723)
15,311
Including rewards and/or remuneration to agents, brokers or other intermediaries
21ncludes CSR expenses paid amounting to =t: Nil lakhs during the half year ended (l{ 264
lakhs for year ended March 31, 2026; a{ 132 lakhs for the half year ended September 30, 2025)
Includes movement in share application money and share issue expenses if any
4 lncludes balance in dividend account which is unclaimed amounting to af 12 lokhs (af 14 k1khs at Morch 31, 2026; "t 19 lakhs at September 30, 2025)
3
The above Receipts and payments account hos been prepared as prescribed by the Insurance Regulatory and Development Authority of India (Actuarial, Finance and Investment Functions of Insurers) Regulations,
2024, as amended under the "Direct method" in accordance with Accounting Standord-3 Cash Flow Statements issued by the Institute of Chartered Accountants of India.
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Statement of Standalone disclosures as per Regulation 52 (4) of SEBI (Listing Obligation and Disclosure requirements) Regulations 2015, as amended,
for the quarter and half year ended September 30, 2026
Three months ended/at
Sr No. Particulars
September 30,
2026
(Unaudited)
June 30, 2026
(Unaudited)
Six months ended/at
Year ended/at
September 30,
September 30,
September 30,
2025
2026
2025
(Unaudited)
(Unaudited)
(Unaudited)
March 31, 2026
(Audited)
1
Debt-Equity Ratio (No. of times) (Note 1)
0.18
0.18
0.20
0.18
0.20
0.19
2
Debt Service Coverage Ratio (DSCR) (No.of times) (not
annualised except year end) (Note 2)
9.45
9.47
8.07
9.46
8.09
10.36
3
4
5
6
7
8
9
Interest Service Coverage Ratio (ISCR) (No.of times)
(not annualised except year end) (Note 3)
Total Borrowings
9.45
9.47
8.07
9.46
8.09
10.36
259,500
259,500
260,000
259,500
260,000
259,500
NA
NA
NA
NA
NA
NA
NA
1,463,328
37,422
NA
1,437,521
38,618
NA
1,272,725
29,926
NA
1,463,328
76,040
NA
1,272,725
60,135
NA
1,363,115
160,036
2.58
2,66
2.07
5.24
4.16
11.06
(net of tax expense) for the period (not annualised
except year end)
Current ratio (Note 6)
Long term debt ta working capital (Note 7)
2.57
1.07
NA
2.66
1.04
NA
2.06
1.23
NA
5.23
1.07
NA
4.13
1.23
NA
11.00
1.13
NA
Bad debts to Account receivable ratio (Note 7)
Current liability ratio (Note 8)
Total debts to total assets (Note 9)*
Debtors turnover (Note 7)
Inventory turnover (Note 7)
Operating margin % (Note 7)
Net profit margin % (Note 7)
NA
0.02
0.01
NA
NA
NA
NA
NA
0.02
0.01
NA
NA
NA
NA
NA
0.01
0.01
NA
NA
NA
NA
NA
0.02
0.01
NA
NA
NA
NA
NA
0.01
0.01
NA
NA
NA
NA
NA
0.02
0.01
NA
NA
NA
NA
Outstanding redeemable preference share (quantity &
value)
Capital Redemption Reserve/Debenture redemption
reserve (Note 4)
Net worth (Note 5) (st in Lakhs)
Net Profit After Tax (st in Lakhs)
Earnings Per Share:
(a) Basic EPS before and after extraordinary items
(net of tax expense) for the period (not annualised
except year end)
(b) Diluted EPS before and after extraordinary items
10
11
12
13
14
15
16
17
18
Notes:
1
2
Debt-Equity Ratio is calculated as total borrowings divided by Equity. Equity is calculated as shareholder's funds excluding redeemable preference shares, if any.
DSCR is calculated as Profit before interest, depreciation and tax (Shareholders account) divided by interest expenses together with principal payments of long
term debt during the period.
3
ISCR is calculated as Profit before interest, depreciation and tax (Shareholders account) divided by interest expenses of long term debt during the period.
4
Capital Redemption Reserve and Debenture redemption reserve is not required to be created as per Companies Act, 2013 and Companies (Share Capital &
5
Debenture) Amendment Rules, 2019 dated August 16, 2019 respectively.
Net worth represents shareholder's funds excluding redeemable preference shares, if any.
6
Current ratio is computed as current assets divided by current liability.
7
8
Not applicable to insurance companies.
Current liability ratio is computed as current liability divided by total liability. Total liability includes borrowings, policyholders' liabilities, fund for future
9
10
appropriation and current liability.
Total debt to total assets is computed as borrowings divided by total assets.
Sector specific equivalent ratios are disclosed in Analytical ratios forming part of Standalone SEBI results.
*represents 0.0078 for the quarter and half year ended September 30, 2026, 0.0077 for the quarter ended June 30, 2026, 0.0080 for the quarter and half year
ended September 30, 2025, 0.0081 for the year ended Morch 31, 2026.
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Other disclosures:
Status of Shareholders Complaints for the quarter ended September 30, 2026:
Sr No.
Number
1
Particulars
No. of investor complaints pending at the beginning of period
2
No. of investor complaints received during the period
3
No. of investor complaints disposed off during the period
0
0
4
No. ot investor complaints remaining unresolved at the end ot the period
0
0
Notes:
1
The above standalone unaudited financial results of the Company for the quarter and half year ended September 30, 2026 were
reviewed by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on October 13, 2026.
2
The above standalone unaudited financial results have been prepared in accordance with the recognition and measurement principles
laid down in Accounting Standard 25 "Interim Financial Reporting" ("AS 25") notified by the Companies (Accounting Standards) Rules,
2021, as prescribed under Section 133 of the Companies Act, 2013, the relevant provision prescribed by IRDAI (Actuarial, Finance and
Investment Functions of Insurers) Regulations, 2024, requirements of Regulation 33 and Regulation 52 read with Regulation 63(2) of
the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time, to the extent applicable
and IRDAI circular IRDAI/F&l/REG/CIR/208/10/2016 dated October 25, 2016 on publication of financial results for life insurance
3
The above standalone unaudited financial results for the quarter and half year ended September 30, 2026 were subjected to limited
review by the joint statutory auditors, M/s M. P. Chitale & Co., Chartered Accountants and M/s Chaturvedi & Co LLP, Chartered
Accountants. The financial results for the corresponding quarter and half year ended September 30, 2025 and the year ended March 31,
2026 included in these statements were reviewed and audited respectively by Mis M P Chitale & Co. (one of the current joint statutory
auditors) jointly with M/s Walker Chandiok & Co LLP, who had issued an unmodified limited review report dated October 14, 2025 and
an unmodified audit report dated April 14, 2026 respectively.
4
In view of seasonality of the industry, the financial results for the quarter and half year ended September 30, 2026 are not indicative of
full year's expected performance.
5
The amounts for the quarter ended September 30, 2026 are balancing amounts between the amounts as per unaudited accounts for the
half year ended September 30, 2026 and unaudited accounts for the quarter ended June 30, 2026. Similarly, the amounts for the quarter
ended September 30, 2025 are balancing amounts between the amounts as per unaudited accounts for the half year ended September
30, 2025 and unaudited accounts for the quarter ended June 30, 2025.
6
During the quarter and half year ended September 30, 2026, the Company has allotted 1,952,518 equity shares of face value of'{ 10
each pursuant to exercise of employee stock options.
7
In furtherance of a request from Prudential Corporation Holdings Limited (PCHL) for reclassification from 'promoter' to 'investor' vide its
letter dated July 5, 2026, the Board of Directors, at its meeting held on July 6, 2026, approved a proposal to change the name of the
Company from 'ICICI Prudential Life Insurance Company Limited' to 'ICICI Life Insurance Limited' and to file an application with the
IRDAI for reclassification of PCHL from 'promoter' to 'investor'. The name change became effective on September 22, 2026, upon
issuance of a fresh Certificate of Incorporation by the Registrar of Companies. The reclassification request is currently under
consideration by IRDAI and accordingly the proposed reclassification has not been given effect to in these financial statements.
8
IRDAI, vide IRDAI (Actuarial, Finance and Investment Functions of Insurers) (Amendment) Regulations, 2026 ("Amended Regulation")
has mandated insurance companies to prepare financial statements in accordance with applicable Indian Accounting Standard (Ind AS)
w.e.f April 1, 2026. The Amended Regulation provides an option to the insurance companies to obtain a forbearance for a period of one
year with prior approval of IRDAI. Pursuant to the above, the Company has obtained approval from IRDAI for such forbearance,
permitting it to defer the adoption of Ind AS by one year. Accordingly, the Company has prepared its financial statements as per the
accounting principles generally accepted in India (Indian GAAP) and Schedule II of the IRDAI (Actuarial, Finance and Investment
Functions of Insurers) Regulations, 2024.
9
Figures of the previous period have been re-grouped wherever necessary, to conform to the current period presentation.
10
In accordance with requirements of IRDAI Circular on "Public disclosures by Insurers" dated December 31, 2021, the Company will
publish the financials on the Company's website latest by October 28, 2026.
For and on F l f of the Board of Directors
M. P. Chitale & Co.
Chartered Accountants
1st Floor, Hamam House,
Ambalal Doshi Marg, Fort
Mumbai-400001
Chaturvedi & Co LLP
Chartered Accountants
81, Mittal Chambers
228, Nariman Point,
Mumbai - 400 021
Independent Auditors' Review Report on Statement of Standalone Unaudited I?inancial
Results of ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance
Company Limited) pursuant to Regulation 33 and Regulation 52 read with Regulation
63(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 read with Insurance Regulatory and Development
Authority of India Circular reference: IRDAI/F&I/REG/CIR/208/10/ 2016 dated 25
October 2016
To
The Board of Directors
ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance Company
Limited)
I. We have reviewed the accompanying statement of standalone unaudited financial results
(the 'Statement') of ICICI Life Insurance Limited (Formerly ICICI Prudential Life
Insurance Company Limited) ('the Company') for the quarter and half year ended 30
September 2026, being submitted by the Company pursuant to requirements of
Regulation 33 and 52 read with Regulation 63(2) of the Securities and Exchange Board of
India ("SEBI") (Listing Obligations and Disclosure Requirements) Regulation, 2015, as
amended (the "Listing Regulations") read with Insurance Regulatory and Development
Authority of India's ("IRDAI" / the "Authority") Circular bearing reference no.
IRDAI/F&l/ REG/ CIR/208/10/2016 dated 25 October 2016 ("IRDAI Circular'').
2. The Statement, which is the responsibility of the Company's Management and approved
by the Company's Board of Directors, has been prepared in accordance with the
requirements of recognition and measurement principles laid down in Accounting
Standard 25, "Interim Financial Reporting" (AS 25) notified by the Companies
(Accounting Standards) Rules, 2021, as prescribed under Section 133 of the Companies
Act, 20 I 3 (the "Act") and other accounting principles generally accepted in India, read
with
the accounting and presentation principles as prescribed in the relevant provisions
of the Insurance Act, 1938 (the "Insurance Act"), as amended from time to time, the
Insurance Regulatory and Development Authority of India Act, 1999 (the "IRDAI Act"),
the IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024
(the "IRDAI Financial Statements Regulations") and orders/directions/circulars issued by
the IRDAI, and has been presented in accordance with the presentation and disclosure
requirements prescribed by the IRDAI Circular and the Listing Regulations, to the extent
applicable. Our responsibility is to express a conclusion on the Statement based on our
review.
3. We conducted our review of the Statement in accordance with the Standard on Review
Engagements (SRE) 2410, "Review of Interim Financial Information Pe,formed by the
Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of
India. This Standard requires that we plan and perform the review to obtain moderate
assurance as to whether the Statement is free from material misstatement. A review of
M. P. Chitale & Co.
Chartered Accountants
Chaturvedi & Co LLP
Chartered Accountants
Independent Auditor's Review Report (Continued)
ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance
Company Limited)
interim financial information consists of making inquiries, primarily of persons
responsible for financial and accounting matters, and applying analytical and other review
procedures. A review is substantially less in scope than an audit conducted in accordance
with the Standards on Auditing specified under section 143(10) of the Companies Act,
2013 and consequently, does not enable us to obtain assurance that we would become
aware of all significant matters that might be identified in an audit. Accordingly, we do not
express an audit opinion.
4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our
attention that causes us to believe that the accompanying Statement prepared in
accordance with the requirements of the recognition and measurement principles laid
down in AS 25 notified by the Companies (Accounting Standards) Rules, 2021,
prescribed under Section 133 of the Act and other accounting principles generally
accepted in India, read with the accounting and presentation principles as prescribed in
the relevant provisions of the Insurance Act, the IRDAI Act and IRDAI Financial
Statements Regulations and orders/directions/circulars issued by the IRDAI, to the extent
applicable, has not presented and disclosed the information required to be disclosed in
terms of the IRDAI Circular and the Listing Regulations, including the manner in which
it is to be disclosed or that it contains any material misstatement.
Emphasis of Matter
5. We draw attention to Note No 8 which states that the company has prepared its financial
statements as per the accounting principles generally accepted in India (Indian GAAP)
and Schedule II of the IRDAI (Actuarial, Finance and Investment Functions of Insurers)
Regulations, 2024 pursuant to forbearance received from IRDAI, permitting it to defer
the adoption of Ind AS for a period of one year.
Our conclusion is not modified in respect of this matter.
Other Matter
6. The actuarial valuation of liabilities for life policies in force and for policies in respect of
which premium has been discontinued but liability exists as at 30 September 2026 is the
responsibility of the Company's Appointed Actuary (the 'Appointed Actuary'). The
actuarial valuation of these liabilities for life policies in force and for policies in respect
of which premium has been discontinued but liability exists as at 30 September 2026 has
been duly certified by the Appointed Actuary, and in his opinion, the assumptions for
such valuation are in accordance with the guidelines, norms and regulations issued by the
IRDAI and the Institute of Actuaries of India in concurrence with the Authority.
Accordingly, we have relied upon the Appointed Actuary's certificate in this regard for
forming our conclusion on the valuation of liabilities for life policies in force and for
policies in respect of which premium has been discontinued but liability exists, as
contained in the Statement of the Company.
Chaturvedi & Co LLP
Chartered Accountants
M. P. Chitale & Co.
Chartered Accountants
Independent Auditor's Review Report (Continued)
ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance
Company Limited)
- The unaudited Standalone Financial Results for the corresponding quarter and half year
ended 30 September 2025 and the audited Standalone Financial Results for the year
ended 31 March 2026, included in the accompanying Standalone Financial results were
reviewed/audited by M.P. Chitale & Co, one of the current joint auditors of the Company,
jointly with Walker Chandiok & Co LLP, who had jointly expressed an unmodified
conclusion/opinion vide their review report dated 14 October 2025 and audit report dated
14 April 2026 respectively, and these reports have been furnished to and relied upon by
Chaturvedi & Co LLP, one of the other current joint auditors, for the purpose of their
joint review of the unaudited Standalone Financial Results.
Our conclusion is not modified in respect of these matters.
For M. P. Chitale & Co.
Chartered Accountants
ICAI FRN: 101851W
For Chaturvedi & Co LLP
Chartered Accountants
ICAI FRN:302137E/E300286
~?-Harnish Shah
Partner
Membership No: 145160
S N Chaturvedi
Partner
Membership No: 040479
UDIN: 26145 I 60YPQMLQ8685
UDIN: 26040479AQCELEI 858
Place: Mumbai
Date: 13 October 2026
Place: Mumbai
Date: 13 October 2026
October 13, 2026
Performance for the half year ended September 30, 2026
- Key updates
The Company has been renamed to ‘ICICI Life Insurance Limited’ marking an important milestone
in its 25-year journey. With the renewed brand identity and a strong financial position, the
Company remains well-placed to enhance customer outcomes, drive sustainable growth, and
deliver long-term value for all its stakeholders.
- Operating performance review
₹ in billion
H1-FY2026
Profit/(Loss) After Tax (PAT)
Value of New Business (VNB)
VNB Margin
Embedded Value
New business received premium
Total premium
Annualised Premium Equivalent (APE)
-Savings APE
-Annuity APE
-Protection APE
New business sum assured (₹ trn)
Retail new business sum assured (₹ trn)
Total in-force sum assured (₹ trn)
Cost/Total premium
Cost/Total premium ex-GST
Savings Cost/Total premium
Savings Cost/Total premium ex-GST
Solvency
Net worth
Assets under management (₹ trn)
6.01
10.49
24.5%
505.01
94.56
212.51
42.86
32.42
2.16
8.28
6.77
1.72
42.16
19.2%
18.6%
12.7%
12.5%
213.2%
127.27
3.21
FY2026
16.00
26.29
24.7%
529.89
248.10
531.25
106.41
81.23
6.13
19.06
14.50
4.50
46.11
18.2%
16.7%
12.1%
11.0%
227.3%
136.31
3.14
H1-FY2027
7.60
12.83
26.0%
566.69
118.21
245.05
49.35
34.55
3.24
11.55
8.81
2.32
49.92
20.0%
18.3%
12.7%
11.6%
229.9%
146.33
3.29
Y-o-Y
26.5%
22.3%
150 bps
12.2%
25.0%
15.3%
15.1%
6.6%
50.0%
39.5%
30.1%
34.9%
18.4%
80 bps
(30 bps)
(90 bps)
16.7%
15.0%
2.3%
Total cost including commission excluding interest on sub debt/Total premium
Y-o-Y: Year-on-year
Persistency
13th month
25th month
37th month
49th month
61st month
12-month rolling persistency
Regular and limited pay
March 31, 2026
June 30, 2026
September 30, 2026
84.5%
84.0%
84.5%
81.0%
77.0%
76.2%
76.3%
77.3%
77.0%
71.8%
71.7%
71.6%
61.6%
61.9%
62.5%
• Profitability
Value of new business (VNB) grew by 22.3% year-on-year from ₹ 10.49 billion in H1-FY2026 to ₹
12.83 billion in H1-FY2027, with a margin of 26.0%.
The Company’s PAT grew by 26.5% year-on-year from ₹ 6.01 billion in H1-FY2026 to ₹ 7.60 billion
in H1-FY2027, primarily driven by higher Shareholders’ investment income and improved surplus
generation in policyholders’ in-force book.
• Embedded Value
The Company’s EV grew by 12.2% year-on-year from ₹ 505.01 billion at September 30, 2025 to ₹
566.69 billion at September 30, 2026. The Value of In-force (VIF) book grew by 12.0% year-on-year
from ₹ 378.40 billion at September 30, 2025 to ₹ 423.89 billion at September 30, 2026.
• Premium
New business received premium grew by 25.0% year-on-year from ₹ 94.56 billion in H1-FY2026 to
₹ 118.21 billion in H1-FY2027. APE grew by 15.1% year-on-year from ₹ 42.86 in H1-FY2026 to ₹
49.35 in H1-FY2027 on the back of 10.6% year-on-year growth in the number of policies reflecting
the continued expansion of customer base. Savings APE stood at ₹ 37.79 billion and overall
protection APE stood at ₹ 11.55 billion.
The overall protection APE registered a strong growth of 39.5% year-on-year in H1-FY2027 driven
by growth across retail and group protection. Retail protection APE grew by 47.2% year on-year
from ₹ 3.09 billion in H1-FY2026 to ₹ 4.55 billion in H1-FY2027. Consequently, in H1-FY2027, sum
assured grew by 30.1% year-on-year to ₹ 8.81 trillion and sum assured market share stood at
11.5%. Retail sum assured increased by 34.9% year-on-year to ₹ 2.32 trillion in H1-FY2027.
Total in-force sum assured, which is the quantum of life cover taken by customers of the Company
stood at ₹ 49.92 trillion at September 30, 2026.
• Product mix
The Company offers a wide range of products across various segments such as savings (linked and
non-linked), annuity and protection to meet the evolving needs of the customers. The Company has
a well-diversified product mix with H1-FY2027 APE contribution from linked, non-linked, protection,
annuity, and group funds at 44.5%, 18.1%, 23.4%, 6.6% and 7.4% respectively.
• Cost efficiency
Over the last few years, the Company has leveraged technology, digital & AI initiatives to improve
productivity while making the cost structure leaner and aligned to the prevailing product mix. As a
result of these initiatives, cost to premium ratio excluding GST reduced by 30 bps year-on-year to
18.3% in H1-FY2027. Savings cost to premium ratio excluding GST reduced by 90 bps year-on-year
to 11.6% in the same period. Including GST, cost to premium ratio increased by 80 bps year-on-year
to 20.0% in H1-FY2027 and savings cost to premium ratio remained stable at 12.7% in the same
period.
• Persistency
The 13th month and 49th month persistency ratio stood at 84.5% and 71.6% respectively at
September 30, 2026.
• Assets under management
The assets under management of the Company stood at ₹ 3.29 trillion at September 30, 2026. The
Company has a debt-equity mix of 59:41, and 95.2% of the fixed income investments are in
sovereign or AAA rated instruments. The Company has zero Non-Performing Assets (NPA) since
inception, indicating high quality of the asset book.
• Net worth and capital position
The Company’s net worth was ₹ 146.33 billion at September 30, 2026. The solvency ratio was
229.9% against the regulatory requirement of 150%.
- Financial performance review
Summary Standalone Revenue and Profit & Loss Account
Particulars
Premium earned
Premium on reinsurance
ceded
Premium on reinsurance
accepted
Net premium earned
Investment income1
Unit-linked
Other than unit-linked
Other income
Total income
Commission paid2
Expenses3
Interest on Non-convertible
Debentures
Tax on policyholders fund
Claims/benefits paid4
Change in actuarial liability5
Total Outgo
Profit/(Loss) before tax
Tax charge/ (credit)
Profit/(Loss) after tax
Three months ended
(₹ in billion)
Year
Six months ended
ended
September September March 31,
30, 2026
30, 2025
2026
245.05
212.51
531.25
(9.52)
(9.05)
(17.89)
September
30, 2026
142.55
(4.51)
June 30,
2026
102.51
(5.01)
September
30, 2025
122.97
(4.54)
138.04
(17.73)
(46.67)
28.95
0.68
121.00
13.76
12.94
0.52
97.49
187.63
157.53
30.11
1.25
286.37
10.14
12.34
0.51
118.43
0.92
(27.37)
28.29
0.58
119.93
12.04
11.24
0.49
235.53
169.91
110.86
59.05
1.93
407.37
23.90
25.28
1.02
203.46
169.84
113.58
56.26
1.11
374.41
21.48
22.47
0.98
513.36
120.71
9.18
111.53
2.31
636.37
51.81
48.26
1.93
0.10
129.24
(39.91)
116.64
4.35
0.61
3.74
0.38
89.50
169.19
282.06
4.31
0.45
3.86
0.47
112.77
(20.55)
116.46
3.47
0.47
2.99
0.49
218.74
129.28
398.70
8.67
1.06
7.60
0.94
210.39
111.23
367.49
6.92
0.90
6.01
(2.53)
471.99
46.84
618.30
18.07
2.06
16.00
- Net of provision for diminution in value of investments
- Commission also includes rewards and/or remuneration to agents, brokers or other intermediaries
- Includes provisions for doubtful debts (including write off) and goods and service tax on linked charges
- Net of reinsurance
- Includes movement in funds for future appropriation
Components may not add up to the totals due to rounding off
The Company’s profit before tax increased from ₹ 6.92 billion in H1-FY2026 to ₹ 8.67 billion in H1-FY2027
primarily driven by higher shareholders’ investment income and improved surplus generation in
policyholders’ in-force book. Profit after tax have increased from ₹ 6.02 billion in H1-FY2026 to ₹ 7.60
billion in H1-FY2027, a year-on-year growth of 26.5%.
The performance highlights for H1-FY2027 are as given below:
•
Net premium earned (gross premium less reinsurance premium) increased by 15.8% from ₹ 203.46
billion in H1-FY2026 to ₹ 235.53 billion in H1-FY2027.
•
Total investment income marginally increased from ₹ 169.84 billion in H1-FY2026 to ₹ 169.91 billion
in H1-FY2027. The movement was driven by the following:
• Investment income under unit-linked decreased marginally from ₹ 113.58 billion in H1-FY2026
to ₹ 110.86 billion in H1-FY2027. Investment income under unit-linked is directly offset by the
change in valuation of policyholder liabilities.
• Investment income under other than unit-linked increased from ₹ 56.26 billion in H1-FY2026 to
₹ 59.05 billion in H1-FY2027 primarily on account of increase in interest income and dividend.
• Total expenses (including commission) increased by 11.7% from ₹ 44.93 billion in H1-FY2026 to ₹
50.20 billion in H1-FY2027. Commission expenses increased by 11.2% from ₹ 21.48 billion in H1FY2026 to ₹ 23.90 billion in H1-FY2027 in line with growth in premium income and product mix.
Operating expense increased by 12.5% from ₹ 22.47 billion in H1-FY2026 to ₹ 25.28 billion in H1FY2027. Operating expenses include unit fund expenses (including goods and service tax on linked
charges) amounting to ₹ 0.29 billion (H1-FY2026: ₹ 3.33 billion) under the unit-linked portfolio. The
unit fund expenses under the unit-linked portfolio are directly offset by changes in the valuation of
policyholder liabilities. Operating expenses of other than unit-linked portfolio increased by 30.6%
from ₹ 19.14 billion in H1-FY2026 to ₹ 24.99 billion in H1-FY2027, primarily on account of higher
GST expenses emanating from disallowance of input tax credit on retail business coupled with
increase in business support, development expenses and wage cost.
•
Claims and benefit payouts (net of reinsurance) increased by 4.0% from ₹ 210.39 billion in H1FY2026 to ₹ 218.74 billion in H1-FY2027 primarily on account of increase in maturity claims partly
offset by decrease in Surrender claims.
•
Change in actuarial liability, including funds for future appropriation and fund reserve, increased
from ₹ 111.23 billion in H1-FY2026 to ₹ 129.28 billion in H1-FY2027. Change in fund reserve, which
represents change in liability carried on account of units held by unit-linked policyholders, increased
from ₹ 43.34 billion in H1-FY2026 to ₹ 74.32 billion in H1-FY2027 primarily on account of lower
benefits outgo coupled with higher premium income. Non-unit reserves, including funds for future
appropriation, decreased from ₹ 67.89 billion in H1-FY2026 to ₹ 54.96 billion in H1-FY2027.
Disclaimer
Except for the historical information contained herein, statements in this release which contain words or phrases such as 'will',
‘expected to’, etc., and similar expressions or variations of such expressions may constitute 'forward-looking statements'.
These forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual results,
opportunities and growth potential to differ materially from those suggested by the forward-looking statements. These risks
and uncertainties include, but are not limited to, the actual growth in demand for insurance and other financial products and
services in the countries that we operate or where a material number of our customers reside, our ability to successfully
implement our strategy, including our use of the Internet and other technology, our exploration of merger and acquisition
opportunities, our ability to integrate mergers or acquisitions into our operations and manage the risks associated with such
acquisitions to achieve our strategic and financial objectives, our growth and expansion in domestic and overseas markets,
technological changes, our ability to market new products, the outcome of any legal, tax or regulatory proceedings in India
and in other jurisdictions we are or become a party to, the future impact of new accounting standards, our ability to implement
our dividend policy, the impact of changes in insurance regulations and other regulatory changes in India and other
jurisdictions on us. ICICI Life Insurance (Formerly known as ICICI Prudential Life Insurance Company Limited) undertakes no
obligation to update forward-looking statements to reflect events or circumstances after the date thereof.
This release does not constitute an offer of securities.
For investor queries please reach out to Investor relations team at +91-22-40391600 or email [email protected].
1 billion = 100 crore
News Release
October 13, 2026
NSE Code: ICICIPRULI
BSE Code: 540133
ICICI Life reports robust PAT growth of 26.5% to
₹ 760 crore in H1-FY2027
Highlights:
•
Company renamed to ‘ICICI Life Insurance Limited’
•
Profit after tax grew by 26.5% year-on-year to ₹ 760 crore in H1-FY2027
•
Value of new business (VNB) grew strongly by 22.3% year-on-year to ₹ 1,283 crore
in H1-FY2027, with a margin of 26.0%
•
Retail New Business Sum Assured grew by 34.9% year-on-year to ₹ 2.32 lakh crore
in H1-FY2027
•
Retail protection APE registered strong growth of 47.2% year-on-year & Annuity
APE grew strongly by 50.0% year-on-year in H1-FY2027
Mumbai, October 13, 2026: The Board of Directors of ICICI Life Insurance Limited
approved and adopted the financial results for the quarter ended September 30, 2026.
The Company has been renamed to ‘ICICI Life Insurance Limited’, marking an important
milestone in its 25-year journey of securing dreams and financial future of more than 20
crore Indians. As this new chapter unfolds, the Company’s commitment of making ‘Har Kal
Aasaan’ for all its stakeholders continues to be guided by its customer-first philosophy.
Thus, reflecting the Company’s broader commitment to make the experience of securing
one’s financial future simpler, more transparent, more flexible and with ease.
The Company continues to focus on protection and annuity segments representing the
under-served needs of Indians. In H1-FY2027, the retail protection segment grew by 47.2%
year-on-year and the annuity segment grew by 50.0% year-on-year. As a result, retail sum
assured increased by 34.9% year-on-year to ₹ 2.32 lakh crore, reflecting a meaningful
expansion in the coverage offered to customers. The Company’s flagship term plan,
iProtect Smart Plus, has been awarded ‘Product of the Year 2026-27’ through NielsenIQ’s
consumer research, a reflection of its commitment to launch innovative and customercentric products.
H1-FY2027 was marked by a challenging macro environment. Despite the external
volatility, the Company’s resilient performance was backed by its well-diversified
distribution network, customer-centric products & processes, industry leading quality
parameters, and strong risk & capital metrics. New business premium grew by 25.0%
year-on-year to ₹ 11,821 crore in H1-FY2027. Value of New Business (VNB) grew by
Page 1 of 5
22.3% year-on-year to ₹ 1,283 crore, with a margin of 26.0%. Profit After Tax (PAT)
increased by 26.5% year-on-year to ₹ 760 crore in H1-FY2027. Embedded Value (EV)
stood at ₹ 56,669 crore, reflecting a year-on-year growth of 12.2%, and the Value of
in-force business (VIF) stood at ₹ 42,389 crore registering a growth of 12.0% year-on-year.
Company continues to leverage economies of scale, technology, Artificial Intelligence (AI),
and digital capabilities to improve efficiency and enhance customer experience. The
Company issued 54% of its savings policies on the same day in H1-FY2027. Cost-topremium ratio excluding GST reduced by 30 bps year-on-year to 18.3% in H1-FY2027 and
savings cost-to-premium ratio excluding GST reduced by 90 bps year-on-year to 11.6% in
the same period.
The Company’s claim settlement ratio stood at 99.3% in H1-FY2027, with an average
turnaround time of 1.1 days for non-investigated claims. During the period, the Company
settled ₹ 2,627 crores of death claims and paid ₹ 8,634 crores as maturity and survival
benefits, reflecting its continued focus on delivering timely financial protection and peace
of mind to customers when needed the most.
Mr. Sidharatha Mishra, Chief Operating Officer (COO) of ICICI Life Insurance Limited
said, “Customer centricity has always been ICICI Life’s core ethos, and this steadfast
commitment will continue to guide all our actions in the years ahead as well. Protection
and annuity remain at the heart of our long-term strategy, addressing deeply
underpenetrated needs in India. Backed by a well-diversified distribution network,
innovative & customer-centric product portfolio, customer-first sales & service, industry
leading quality parameters, strong risk & capital metrics, we are a resilient organisation
that can successfully capitalise on emerging opportunities. Our commitment is to deliver
sustainable VNB growth while balancing business, profitability and risk & prudence.”
Key performance highlights:
▪
Premium: New business received premium grew by 25.0% year-on-year from ₹ 9,456
crore in H1-FY2026 to ₹ 11,821 crore in H1-FY2027. Annualised Premium Equivalent
(APE) grew by 15.1% year-on-year from ₹ 4,286 crore in H1-FY2026 to ₹ 4,935 crore
in H1-FY2027. The overall protection APE registered a growth of 39.5% year-on-year
in H1-FY2027. Retail protection APE grew by 47.2% year-on-year from ₹ 309 crore in
H1-FY2026 to ₹ 455 crore in H1-FY2027. Annuity APE grew by 50.0% year-on-year
from ₹ 216 crore in H1-FY2026 to ₹ 324 crore in the same period.
▪
Sum assured: Retail new business sum assured grew strongly by 34.9% year-on-year
to ₹ 2.32 lakh crore in H1-FY2027. The total in-force sum assured, which is the
quantum of life cover taken by customers of the Company, grew by 18.4% year-onyear from ₹ 42.16 lakh crore at September 30, 2025, to ₹ 49.92 lakh crore at September
30, 2026.
Page 2 of 5
▪
Cost: Cost to premium ratio (without GST) reduced by 30 bps year-on-year to 18.3%
in H1-FY2027. Savings cost to premium ratio (without GST) reduced by 90 bps yearon-year to 11.6% in the same period. Including GST, cost to premium ratio increased
by 80 bps year-on-year to 20.0% in H1-FY2027 and savings cost to premium ratio
remained stable at 12.7% in the same period.
▪
Profitability: The Value of New Business (VNB) grew by 22.3% year-on-year and stood
at ₹ 1,283 crore with a margin of 26.0% in H1-FY2027. Profit after tax (PAT) grew by
26.5% year-on-year from ₹ 601 crore in H1-FY2026 to ₹ 760 crore in H1-FY2027.
▪
Embedded Value: EV grew by 12.2% year-on-year to ₹ 56,669 crore and Value of Inforce business (VIF) grew by 12.0% year-on-year to ₹ 42,389 crore as on September
30, 2026.
▪
Claim Settlement Ratio: Claim settlement ratio stood at 99.3% with an average
turnaround time of 1.1 day for non-investigated individual death claims in H1-FY2027.
▪
Persistency: 13th month and 49th month persistency stood at 84.5% and 71.6%
respectively in H1-FY2027.
▪
Solvency Ratio: Solvency ratio stood at 229.9% as on September 30, 2026, against the
regulatory requirement of 150%.
▪
Assets under Management (AUM): AUM stood at ₹ 3.29 lakh crore as on September
30, 2026.
▪
ESG: The Company continues to retain one of the highest rankings in the Indian life
insurance industry as per leading global and Indian ESG rating agencies.
Financial metrics:
` crore
H1-FY2026
H1-FY2027
Y-o-Y
Profit After Tax (PAT)
601
760
26.5%
Value of New Business (VNB)
1,049
1,283
22.3%
VNB Margin
24.5%
26.0%
150 bps
Embedded Value
50,501
56,669
12.2%
New Business Received Premium
9,456
11,821
25.0%
Total Premium
21,251
24,505
15.3%
Annualised Premium Equivalent (APE)
4,286
4,935
15.1%
• Savings
3,242
3,455
6.6%
• Annuity
216
324
50.0%
• Protection
828
1,155
39.5%
Page 3 of 5
` crore
H1-FY2026
H1-FY2027
Y-o-Y
Product mix (% of APE): Linked/nonlinked/annuity/protection/group funds
48/22/5/19/6
45/18/7/23/7
25/14/30/13/18
22/14/27/15/22
1.72
2.32
34.9%
6.77
8.81
30.1%
Channel mix (% of APE):
Agency/direct/ banca/partnership
distribution/group
Retail NB Sum Assured (₹ lakh crore)
NB Sum Assured (₹ lakh crore)
Total in-force sum assured (₹ lakh
crore)
Cost/Total premium
42.16
49.92
18.4%
19.2%
20.0%
80 bps
Cost/Total premium ex-GST
18.6%
18.3%
(30 bps)
Savings Cost/Total premium
12.7%
12.7%
Savings Cost/Total premium ex-GST
12.5%
11.6%
(90 bps)
Solvency
Assets under Management (AUM) (₹
lakh crore)
213.2%
229.9%
16.7%
3.21
3.29
2.3%
Components may not add up to the totals due to rounding off
Total cost including commission excluding interest on sub-debt/ Total premium
Y-o-Y: year-on-year
Definitions, abbreviations and explanatory notes
• Annual Premium Equivalent (APE): APE is a measure of new business written by a life
insurance company. It is computed as the sum of annualised first year premiums on regular
premium policies, and ten percent of single premiums, written by the Company during any period
from new retail and group customers.
• Retail Weighted Received Premium (RWRP): RWRP is a new business measure very similar to
APE for the retail (also referred to as individual) business with the only difference being that the
regular premiums considered here are first year premiums actually received by the life insurer
and not annualised. It is the sum of all retail first year premiums and ten percent of retail single
premiums received in a period.
• New Business Received Premium: It is a measure of the new business generated during the
period and reflects the total inflow of premium from newly acquired retail plus group policies.
•
Sum assured: The amount that an insurer agrees to pay upon the occurrence of a stated
contingency, in accordance with the terms and conditions of the policy.
•
Persistency: It is the most common parameter for quality of business representing the
percentage of retail policies (where premiums are expected) that continue paying premiums.
Regular and Limited pay persistency in accordance with IRDAI Master circular on Submission of
Returns 2024 dated June 14, 2024.
•
Cost Ratio: Cost ratio is a measure of the cost efficiency of a Company. It is calculated as a ratio
of expenses incurred by the Company on new business as well as renewal premiums excluding
interest on sub-debt to total premium.
Page 4 of 5
• Value of New Business (VNB) and VNB margin: VNB is used to measure profitability of the new
business written in a period. It is present value of all future profits to shareholders measured at
the time of writing of the new business contract. Future profits are computed on the basis of
long-term assumptions which are reviewed annually. VNB is also referred to as NBP (new
business profit). VNB margin is computed as VNB for the period/APE for the period. It is similar
to profit margin for any other business.
•
Embedded Value (EV): EV represents the present value of shareholders’ interests in the earnings
distributable from the assets allocated to the business after sufficient allowance for the
aggregate risks in the business.
For further press queries email us on [email protected]
About ICICI Life Insurance Limited:
ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance Company Limited) commenced operations in FY2001
and has since established itself as one of India’s leading life insurers, consistently ranking high on both sum assured market
share and new business premium market share. Over the years, it has earned the unwavering trust of millions of customers,
becoming an integral part of India’s financial ecosystem.
Customer centricity has remained the foundation of its philosophy, with products, processes and distribution strategies all
aligned to a single objective: delivering a strong and differentiated value proposition for customers. The Company offers a
comprehensive suite of Protection, Savings & Retirement solutions designed to meet the evolving life stage needs. These
offerings enable customers to safeguard their families’ financial security while also achieving long term financial goals.
As on March 31, 2026, the Company protects 73.73 million lives (in-force) across India covering both individual and corporate
segments, making it one of the leading insurance companies in the country. Over the years, the Company has delivered on
its promise of financial protection by settling ₹ 279 billion in death claims and paying ₹ 3.72 trillion in overall benefits as of
March 31, 2026. In FY2026 alone, it settled ₹ 51.49 billion in death claims and disbursed ₹ 153.63 billion in maturity and
survival benefits. Its claim settlement ratio of 99.3 percent and average turnaround time of 1 day underscore its commitment
to swift, reliable service.
The Company is also the first among Indian Insurance industry to get listed on both the NSE and BSE. Its continued
investments in data analytics and digitisation across the policy lifecycle have enabled superior efficiency, innovation and
seamless experiences for customers and distributors alike.
Disclaimer
Except for the historical information contained herein, statements in this release which contain words or phrases such as
'will', ‘expected to,’ etc., and similar expressions or variations of such expressions may constitute 'forward-looking
statements'. These forward-looking statements involve a number of risks, uncertainties and other factors that could cause
actual results, opportunities and growth potential to differ materially from those suggested by the forward-looking
statements. These risks and uncertainties include, but are not limited to, the actual growth in demand for insurance and
other financial products and services in the countries that we operate or where a material number of our customers reside,
our ability to successfully implement our strategy, including our use of the Internet and other technology, our exploration of
merger and acquisition opportunities, our ability to integrate mergers or acquisitions into our operations and manage the
risks associated with such acquisitions to achieve our strategic and financial objectives, our growth and expansion in
domestic and overseas markets, technological changes, our ability to market new products, the outcome of any legal, tax or
regulatory proceedings in India and in other jurisdictions we are or become a party to, the future impact of new accounting
standards, our ability to implement our dividend policy, the impact of changes in insurance regulations and other regulatory
changes in India and other jurisdictions on us. The Company undertakes no obligation to update forward-looking statements
to reflect events or circumstances after the date thereof. This release does not constitute an offer of securities.
Page 5 of 5
Searchable format
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Statement of Standalone Unaudited Results for the quarter and half year ended September 30, 2026
(₹ in Lakhs)
Sr
No.
Particulars
Three months ended/at
September 30,
June 30,
September 30,
2026
(Unaudited)
POLICYHOLDERS’ ACCOUNT
Gross premium income
(a) First Year Premium
1
(b) Renewal Premium
(c) Single Premium
2 Net premium income1
3 Income from investments: (Net)2
4 Other income
5 Transfer of funds from Shareholders’ A/c
6 Total (2 to 5)
2026
(Unaudited)
2025
(Unaudited)
Six months ended/at
September 30, September 30,
2026
(Unaudited)
2025
(Unaudited)
Year ended/at
March 31,
2026
(Audited)
214,570
729,647
481,242
1,380,390
(212,329)
6,625
(421)
171,186
538,360
315,517
974,933
1,850,024
9,360
5,173
197,517
685,178
347,008
1,184,310
(22,667)
5,792
34,129
385,756
1,268,007
796,759
2,355,323
1,637,695
15,985
4,752
342,059
1,179,343
603,705
2,034,629
1,642,192
11,034
45,724
1,637,685
5,133,563
1,086,515
1,174,265
2,839,490
1,201,564
4,013,755
3,733,579
6,342,038
51,886
14,736
70,933
137,555
30,423
10,364
60,629
101,416
47,562
15,189
57,625
120,376
82,309
25,100
131,562
238,971
80,443
25,984
108,384
214,811
210,985
60,097
247,025
518,107
55,108
72,754
51,171
70,161
46,447
48,361
106,279
142,915
95,312
94,170
187,900
254,711
10 Expenses of Management (8+9)
11 Provisions for doubtful debts (including bad debts written off)
265,417
570
222,748
641
215,184
2,041
488,165
1,211
404,293
2,489
960,718
5,821
12 Provisions for/(reversal of) diminution in value of investments
13 Goods and Services tax on ULIP charges
Provision for taxes (a+b)
14
(a) Current tax (credit)/charge
(b) Deferred tax (credit)/charge
15 Benefits Paid 4 (Net)1
16 Change in actuarial liability
17 Total (10+11+12+13+14+15+16)
18 Surplus/(Deficit) (6-17)
896
1,045
1,045
1,292,389
(405,023)
845
3,845
3,845
894,985
1,668,814
15,427
4,682
4,682
1,127,681
(211,943)
1,741
4,890
4,890
2,187,374
1,263,791
32,108
9,358
9,358
2,103,919
1,095,296
(1,614)
33,575
(25,296)
(25,296)
4,719,880
402,744
1,155,294
18,971
2,791,878
47,612
1,153,072
48,492
3,947,172
66,583
3,647,463
86,116
6,095,828
246,210
7
8
9
Commission on
(a) First Year Premium
(b) Renewal Premium
(c) Single Premium
Net Commission3
Operating Expenses related to insurance business
(a) Employees remuneration and welfare expenses
(b) Other operating expenses
843,223
2,831,556
22,987
98,973
19
Appropriations
(a) Transferred to Shareholders
(b) Funds for Future Appropriations
13,100
5,871
24,504
23,108
42,032
6,460
37,604
28,979
69,093
17,023
180,520
65,690
20
Details of Surplus/(Deficit)
(a) Interim and other bonuses paid
(b) Allocation of bonus to policyholders
(c) Surplus shown in the Revenue Account
22,098
18,971
19,937
47,612
21,305
48,492
42,035
66,583
37,541
86,116
98,670
67,659
246,210
41,069
67,549
69,797
108,618
123,657
412,539
13,100
24,504
42,032
37,604
69,093
180,520
35,073
197
5,259
(421)
26,314
3,106
5,629
5,173
31,833
22
5,057
34,129
61,387
3,303
10,888
4,752
56,674
41
10,386
45,724
513
126,588
99
19,893
98,973
28
7,638
43,532
6,110
6,110
43,122
4,504
4,504
34,701
4,775
4,775
86,654
10,614
10,614
69,185
9,050
9,050
180,675
20,639
20,639
37,422
38,618
29,926
76,040
60,135
160,036
37,422
38,618
29,926
76,040
60,135
160,036
Dividend per share (₹) (Nominal Value ₹ 10 per share):
(a) Interim Dividend
(b) Final Dividend
Profit/(Loss) carried to Balance Sheet
Paid up equity share capital
Reserve & Surplus (excluding Revaluation Reserve)
Fair value Change Account and revaluation reserve
867,633
145,123
1,278,566
39,639
830,211
145,078
1,238,998
53,422
715,626
144,677
1,106,910
21,138
867,633
145,123
1,278,566
39,639
715,627
144,677
1,106,910
21,138
1.65
815,528
144,928
1,218,184
(167)
Total Assets:
(a) Investments:
- Shareholders’
37
- Policyholders Fund excluding Linked Assets
- Assets held to cover Linked Liabilities
(b) Other Assets (Net of current liabilities and provisions)
1,644,753
14,761,149
15,848,413
431,912
1,632,197
14,583,206
16,541,489
409,354
1,583,411
1,644,753
1,583,411
1,572,759
13,440,521
16,557,342
450,447
14,761,149
15,848,413
431,912
13,440,521
16,557,342
450,447
14,129,952
15,105,238
464,573
Total Surplus
SHAREHOLDERS’ ACCOUNT
21 Transfer from Policyholders’ Account
Total income under Shareholders’ Account
22
(a) Investment Income
(b) Other income
23
24
25
26
27
Expenses other than those related to insurance business
Transfer of funds to Policyholders A/c
Provisions for doubtful debts (including write off)
Provisions for diminution in value of investments
Profit/(loss) before tax
Provisions for tax (a+b)
28
(a) Current tax (credit)/charge
(b) Deferred tax (credit)/charge
29 Profit/(loss) after tax and before extraordinary items
30 Extraordinary Items (Net of tax expenses)
31 Profit/(loss) after tax and extraordinary items
32
33
34
35
36
Foot Notes:
1 Net of reinsurance
2 Net of amortisation and losses (including capital gains)
3 Inclusive of rewards and/or remuneration to agents, brokers or other intermediaries
4 Inclusive of interim and other bonuses
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Standalone Balance Sheet at September 30, 2026
(₹ in Lakhs)
Particulars
Sources of funds
Shareholders' funds:
Share capital
Share application money
Reserve and surplus
Credit/[Debit] fair value change account
Sub - total
At September 30,
At June 30,
At March 31,
At September 30,
2026
2026
2026
2025
(Unaudited)
(Unaudited)
(Audited)
(Unaudited)
145,123
1,291,502
26,703
1,463,328
145,078
23
1,251,934
40,486
1,437,521
144,928
170
1,231,120
(13,103)
1,363,115
144,677
1,110,939
17,109
1,272,725
259,500
259,500
259,500
260,000
210,941
5,347
317,616
5,347
190,219
5,347
396,349
4,422
Policy liabilities
Insurance Reserve
14,675,711
14,387,657
14,155,095
13,395,542
Provision for linked liabilities (fund reserves) (A)
(a) Provision for linked liabilities
(b) Credit/[Debit] fair value change account (Linked)
15,228,196
13,506,153
1,722,043
15,922,490
13,322,778
2,599,712
14,527,436
13,181,446
1,345,990
15,949,012
12,826,205
3,122,807
Funds for discontinued policies (B)
(a) Discontinued on account of non-payment of premium
(b) Other discontinuance
(c) Credit/[debit] fair value change account
Total linked liabilities (A)+(B)
Sub - total
620,217
619,897
320
15,848,413
30,740,412
618,999
618,649
350
16,541,489
31,252,109
577,802
577,458
344
15,105,238
29,455,899
608,330
607,539
376
415
16,557,342
30,353,655
4,247
218,740
222,987
3,789
213,327
217,116
3,188
190,820
194,008
2,399
142,942
145,341
Total
32,686,227
33,166,246
31,272,522
32,031,721
Application of funds
Investments
Shareholders’
Policyholders’
Asset held to cover linked liabilities
Loans
Fixed assets - net block
1,644,753
14,761,149
15,848,413
321,666
71,540
1,632,197
14,583,206
16,541,489
312,549
72,001
1,572,759
14,129,952
15,105,238
300,623
71,100
1,583,411
13,440,521
16,557,342
272,662
83,071
Current assets
Cash and Bank balances
Advances and Other assets
Sub-Total (A)
15,311
596,554
611,865
13,758
627,086
640,844
113,770
680,051
793,821
13,719
500,867
514,586
Current liabilities
Provisions
Sub-Total (B)
Net Current Assets (C) = (A-B)
568,643
4,516
573,159
38,706
611,263
4,777
616,040
24,804
696,631
4,340
700,971
92,850
416,440
3,432
419,872
94,714
32,686,227
76,823
33,166,246
82,043
31,272,522
82,644
32,031,721
106,189
Borrowings
Policyholders' funds:
Credit/[Debit] fair value change account
Revaluation reserve - Investment property
Funds for Future Appropriations
Linked
Non linked
Sub - total
Miscellaneous expenditure (to the extent not written-off or adjusted)
Debit Balance in Profit & Loss Account (Shareholders' account)
Total
Contingent liabilities
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Segment Reporting (Standalone) for the quarter and half year ended September 30, 2026
1
(₹ in Lakhs)
Three months ended/at
Sr
No.
1
Particulars
Six months ended/at
September 30,
June 30,
September 30,
September 30,
September 30,
Year ended/at
March 31,
2026
(Unaudited)
2026
(Unaudited)
2025
(Unaudited)
2026
(Unaudited)
2025
(Unaudited)
2026
(Audited)
Segment Income:
Segment A: Par life
Net Premium
140,160
83,900
137,905
224,060
216,796
542,186
Income from investments2
Transfer of Funds from shareholders' account
Other income
86,167
3,550
68,963
6,336
82,151
3,198
155,130
9,886
150,366
6,182
296,053
121
12,787
Segment B: Par pension
Net Premium
11,395
5,848
6,834
17,243
11,680
46,484
2,961
14
2,815
13
2,633
3
5,776
27
5,764
4
11,055
29
13
489,843
358,109
342,951
847,952
640,996
1,731,323
124,230
(3,958)
2,804
161,222
5,173
2,791
132,047
33,968
2,445
285,452
1,215
5,595
275,044
45,501
4,588
539,381
76,831
9,566
6,704
12,282
5,178
18,986
8,893
78,995
3,899
3
3,742
3,097
7,641
3
7,286
13,526
7
Net Premium
Income from investments2
Transfer of Funds from shareholders' account
4
3
6
(4)
7
33
56
42
58
Income from investments2
Transfer of Funds from shareholders' account
Other income
Segment C: Non Par Life
Net Premium
Income from investments2
Transfer of Funds from shareholders' account
Other income
Segment D: Non Par Pension
Net Premium
Income from investments2
Transfer of Funds from shareholders' account
Other income
Segment E: Non Par Variable Life
Other income
Segment F: Non Par Variable Pension
Net Premium
41
36
41
127
359
22
29
33
(2)
51
67
129
Segment G: Annuity Non Par
Net Premium
78,369
50,040
62,598
128,409
114,069
264,158
Income from investments2
Transfer of Funds from shareholders' account
Other income
33,756
3,443
187
34,155
150
27,266
82
67,911
3,443
337
59,790
141
119,003
21,249
321
2
Income from investments
Transfer of Funds from shareholders' account
Other income
Segment H: Health Non Par
797
636
707
1,433
1,395
2,936
2
238
236
1
82
1
474
1
333
1
818
1
2
500,489
390,409
481,490
890,898
839,967
1,961,303
2
(434,339)
70
1,448,755
69
(262,438)
62
1,014,416
139
1,045,775
117
60,256
454
275
Net Premium
Income from investments
Transfer of Funds from shareholders' account
Other income
Segment I: Linked Life
Net Premium
Income from investments
Transfer of Funds from shareholders' account
Other income
Segment J: Linked Pension
Net Premium
Income from investments2
Transfer of Funds from shareholders' account
Other income
Segment K: Linked Health
Net Premium
6,080
4,138
4,582
10,218
6,903
19,068
(14,119)
50,686
(9,851)
36,567
42,067
9,436
8
(157)
(227)
(131)
(384)
(339)
6
(2,564)
11,231
(1,699)
8,667
8,570
2,229
1
Net Premium
135,002
49,920
133,302
184,922
173,877
431,461
Income from investments2
Transfer of Funds from shareholders' account
Other income
(10,156)
91
49,765
2,319
167
1
39,609
91
30,744
167
1
22,514
221
15
Income from investments2
Transfer of Funds from shareholders' account
Other income
Segment L: Linked Group Life
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Segment Reporting (Standalone) for the quarter and half year ended September 30, 2026
1
(₹ in Lakhs)
Three months ended/at
Sr
No.
Particulars
Six months ended/at
September 30,
June 30,
September 30,
September 30,
September 30,
Year ended/at
March 31,
2026
(Unaudited)
2026
(Unaudited)
2025
(Unaudited)
2026
(Unaudited)
2025
(Unaudited)
2026
(Audited)
Segment M: Linked Group Pension
Net Premium
11,708
19,837
8,858
31,545
20,265
55,284
Income from investments2
Transfer of Funds from shareholders' account
Other income
(2,428)
18,422
1,687
15,994
16,353
13,687
1
Other income
35,073
197
26,314
3,106
31,833
22
61,387
3,303
56,161
41
118,950
99
Segment Surplus/(Deficit) (net of transfer from shareholders’ A/c):
Segment A: Par life
Segment B: Par pension
Segment C: Non Par Life
Segment D: Non Par Pension
Segment E: Non Par Variable Life
Segment F: Non Par Variable Pension
Segment G: Annuity Non Par
Segment H: Health Non Par
Segment I: Linked Life
Segment J: Linked Pension
Segment K: Linked Health
Segment L: Linked Group Life
Segment M: Linked Group Pension
Shareholders
6,000
(587)
3,958
(54)
1
(5,685)
315
13,400
1,125
1,048
(545)
416
23,901
22,533
(26)
(5,173)
51
7
2
2,242
413
19,406
1,629
745
454
156
19,287
6,173
(143)
(33,968)
(277)
4
8
1,990
48
39,330
1,646
81
(917)
388
22,023
28,533
(613)
(1,215)
(3)
8
2
(3,443)
728
32,806
2,754
1,793
(91)
572
43,188
17,372
(1,261)
(45,501)
757
(56)
6
15,780
894
47,404
3,840
686
(167)
638
36,766
84,357
(2,037)
(76,831)
918
(58)
10
(21,249)
3,059
148,056
7,008
2,927
(221)
1,298
78,489
Shareholders
Income from investments2
2
3
Segment Assets:
Segment A: Par life
Segment B: Par pension
Segment C: Non Par Life
Segment D: Non Par Pension
Segment E: Non Par Variable Life
Segment F: Non Par Variable Pension
Segment G: Annuity Non Par
Segment H: Health Non Par
Segment I: Linked Life
Segment J: Linked Pension
Segment K: Linked Health
Segment L: Linked Group Life
Segment M: Linked Group Pension
Shareholders
4,100,405
180,665
8,388,638
216,207
200
1,016
2,065,117
13,916
13,761,055
512,060
129,021
1,170,770
424,329
1,722,828
4,092,615
172,008
8,299,008
208,206
197
1,959
2,002,819
13,654
14,474,374
540,861
134,258
1,098,342
430,924
1,697,021
4,043,774
142,710
7,555,843
164,284
426
2,007
1,818,483
14,606
14,705,783
584,115
136,316
912,920
417,729
1,532,724
4,100,405
180,665
8,388,638
216,207
200
1,016
2,065,117
13,916
13,761,055
512,060
129,021
1,170,770
424,329
1,722,828
4,043,774
142,710
7,555,843
164,284
426
2,007
1,818,483
14,606
14,705,783
584,115
136,316
912,920
417,729
1,532,724
3,996,354
166,996
8,091,158
203,672
207
1,932
1,944,421
13,578
13,145,627
502,255
125,401
1,046,998
411,308
1,622,615
4
Segment Policy Liabilities3:
Segment A: Par life
Segment B: Par pension
Segment C: Non Par Life
Segment D: Non Par Pension
Segment E: Non Par Variable Life
Segment F: Non Par Variable Pension
Segment G: Annuity Non Par
Segment H: Health Non Par
Segment I: Linked Life
Segment J: Linked Pension
Segment K: Linked Health
Segment L: Linked Group Life
Segment M: Linked Group Pension
4,100,405
180,665
8,388,638
216,207
200
1,016
2,065,117
13,916
13,761,055
512,060
129,021
1,170,770
424,329
4,092,615
172,008
8,299,008
208,206
197
1,959
2,002,819
13,654
14,474,374
540,861
134,258
1,098,342
430,924
4,043,774
142,710
7,555,843
164,284
426
2,007
1,818,483
14,606
14,705,783
584,115
136,316
912,920
417,729
4,100,405
180,665
8,388,638
216,207
200
1,016
2,065,117
13,916
13,761,055
512,060
129,021
1,170,770
424,329
4,043,774
142,710
7,555,843
164,284
426
2,007
1,818,483
14,606
14,705,783
584,115
136,316
912,920
417,729
3,996,354
166,996
8,091,158
203,672
207
1,932
1,944,421
13,578
13,145,627
502,255
125,401
1,046,998
411,308
Footnotes:
1 Segments are as under:
(a) Linked Policies (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable
(b) Non-Linked
- Non-Participating Policies: (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable
- Participating Policies: (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable
(c) Variable insurance shall be further segregated into Life and Pension
2 Net of provisions/(reversal) for diminution in value of investments.
3 Includes the fund for future appropriations, fair value change and revaluation reserve of investment property.
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Statement of Standalone Unaudited Results for the quarter and half year ended September 30, 2026
Three months ended/at
Sr
September 30,
Particulars
No.
2026
(Unaudited)
June 30, 2026
(Unaudited)
Six months ended/at
Year ended/at
September
September 30,
September 30,
30, 2025
2026
2025
(Unaudited)
(Unaudited)
(Unaudited)
March 31, 2026
(Audited)
1
Analytical Ratios:
Solvency Ratio:
Expenses of management ratio
(i)
(ii)
(iii)
(iv)
Policyholder’s liabilities to shareholders’ fund
229.9%
18.6%
2116.0%
225.4%
21.8%
2189.1%
213.2%
17.5%
2396.4%
229.9%
19.9%
2116.0%
213.2%
19.0%
2396.4%
227.3%
18.1%
2175.2%
2.58
2.66
2.07
5.24
4.16
11.06
2.57
2.66
2.06
5.23
4.13
11.00
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
9.4%
7.0%
10.5%
7.8%
7.4%
8.0%
9.4%
7.7%
11.1%
8.6%
7.2%
9.3%
8.7%
8.1%
11.3%
8.5%
7.8%
10.5%
(3.9%)
(4.1%)
(12.1%)
23.5%
20.8%
47.0%
(0.5%)
(0.8%)
(7.7%)
8.9%
7.5%
13.7%
8.9%
2.0%
13.0%
3.1%
0.4%
(1.0%)
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
NIL
8.6%
(1.8%)
6.6%
29.0%
8.2%
1.1%
7.6%
12.5%
7.3%
9.7%
7.8%
5.5%
83.9%
74.5%
72.9%
70.7%
62.3%
83.4%
74.0%
72.5%
69.9%
63.3%
81.4%
78.5%
74.4%
70.6%
59.5%
84.5%
76.2%
77.0%
71.6%
62.5%
84.7%
82.8%
75.0%
70.7%
62.6%
83.1%
76.5%
76.6%
71.1%
61.7%
83.2%
74.9%
67.6%
60.8%
60.3%
82.7%
74.7%
67.0%
61.5%
61.7%
79.9%
71.5%
64.8%
63.5%
54.6%
82.8%
74.8%
68.4%
62.7%
59.4%
81.8%
73.3%
65.8%
63.3%
62.8%
81.8%
73.2%
67.1%
63.4%
57.7%
83.2%
93.1%
87.9%
NA
NA
NA
85.5%
111.9%
79.3%
80.7%
95.2%
99.8%
102.4%
82.6%
61.2%
84.0%
NA
NA
NA
151.9%
96.3%
83.1%
97.0%
95.2%
101.2%
99.0%
82.7%
86.1%
89.1%
NA
NA
NA
64.3%
78.7%
79.5%
66.4%
96.6%
42.5%
118.5%
83.0%
79.8%
86.2%
NA
NA
NA
101.8%
104.2%
81.0%
86.2%
95.2%
100.1%
100.5%
80.6%
70.1%
88.4%
NA
NA
NA
50.1%
82.1%
80.4%
67.9%
95.7%
41.6%
108.8%
79.9%
91.6%
88.5%
NA
NA
NA
56.7%
86.0%
79.7%
75.5%
93.0%
51.1%
115.6%
Earnings per share (₹):
(a) Basic EPS before and after extraordinary items (net of tax expense)
for the period (not annualised except year end)
(b) Diluted EPS before and after extraordinary items (net of tax
expense) for the period (not annualised except year end)
NPA ratios: (for policyholders' fund)
(a) Gross & Net NPAs
(b) % of Gross & Net NPAs
(v)
Yield on Investments (on policyholders' fund)
(vi)
A. Without unrealised gains
- Non Linked Par
- Non Linked Non Par
- Linked Non Par
B. With unrealised gains
- Non Linked Par
- Non Linked Non Par
- Linked Non Par
(vii) NPA ratios: (for shareholders' fund)
(a) Gross & Net NPAs
(b) % of Gross & Net NPAs
(viii) Yield on Investments (on Shareholders' A/c)
A. Without unrealised gains
B. With unrealised gains
(ix)
Persistency Ratio (Regular Premium / Limited Premium Payment under
Individual category)
2
Premium Basis
13th month
25th month
37th month
49th month
61st month
Number of Policy Basis
13th month
25th month
37th month
49th month
61st month
Conservation Ratio
Par Life
Par Pension
Non Par Life
Non Par Pension
Non Par Variable
Non Par Variable Pension
Annuity Non Par
Health
Linked Life
Linked Pension
Linked Health
Linked Group Life
Linked Group Pension
(x)
Notes:
1
Analytical ratios have been calculated as per the definition given in IRDAI Analytical ratios disclosure.
2
Calculations are in accordance with the IRDAI circular IRDAI/NL/MSTCIR/RT/93/6/2024 dated June 14, 2024.
a) Persistency ratios for the quarter ended September 30, 2026 have been calculated on September 30, 2026 for the policies issued in June to August period of the relevant years. For
example, the 13th month persistency for quarter ended September 30, 2026 is calculated for policies issued from June 1, 2025 to August 31, 2025
b) Persistency ratios for the quarter ended June 30, 2026 have been calculated on July 31, 2026 for the policies issued in April to June period of the relevant years. For example, the
13th month persistency for quarter ended June 30, 2026 is calculated for policies issued from April 1, 2025 to June 30, 2025.
c) Persistency ratios for the quarter ended September 30, 2025 have been calculated on October 31, 2025 for the policies issued in July to September period of the relevant years. For
example, the 13th month persistency for quarter ended September 30, 2025 is calculated for policies issued from July 1, 2024 to September 30, 2024.
d) Persistency ratios for the year ended September 30, 2026 have been calculated on September 30, 2026 for the policies issued in September to August period of the relevant years.
For example, the 13th month persistency for year ended September 30, 2026 is calculated for policies issued from September 1, 2024 to August 31, 2025
e) Persistency ratios for the year ended September 30, 2025 have been calculated on October 31, 2025 for the policies issued in October to September period of the relevant years. For
example, the 13th month persistency for year ended September 30, 2025 is calculated for policies issued from October 1 , 2023 to September 30, 2024.
f) Persistency ratios for the year ended March 31, 2026 have been calculated on April 30, 2026 for the policies issued in April to March period of the relevant years. For example, the
13th month persistency for year ended March 31, 2026 is calculated for policies issued from April 1, 2024 to March 31, 2025.
g) Group policies and policies under micro insurance products are excluded.
ICICI Life Insurance Limited (Formerly known as ICICI Prudential Life Insurance Company Limited)
Unaudited Condensed Interim Standalone Receipts & Payments Account for the half year ended September 30, 2026
(₹ in lakhs)
Particulars
Half Year ended September 30, 2026
Year ended March 31, 2026
Half Year ended September 30, 2025
(Unaudited)
(Audited)
(Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES
Premium and other receipts (net of Goods and Services tax)
Fees & Charges
Interest received on tax refund
Payments to the re-insurers, net of commissions and claims
Payments to co-insurers, net of claims recovery
Payments of claims
2,520,242
38,875
5,928
5,431,969
46,364
2,235,154
29,557
(17,744)
(2,255,452)
(12,678)
(4,863,563)
(9,309)
(2,161,946)
Payments of commission and brokerage1
(251,811)
(512,499)
(256,023)
Payments of other operating expenses2
Preliminary and pre-operative expenses
Deposits, advances and staff loans
Income taxes paid (Net)
Goods and Services tax paid
Other payments
Cash flows before extraordinary items
Cash flow from extraordinary operations
Net cash flow from / (used in) operating activities (A)
(279,504)
(1,891)
30,631
(41,282)
(469,377)
(3,108)
(58,835)
(92,983)
(254,193)
(2,137)
(22,045)
(65,265)
(2,817,053)
(252,008)
(252,008)
(6,013,043)
(534,710)
(534,710)
(2,770,918)
(506,207)
(506,207)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of fixed assets
Proceeds from sale of fixed assets
Purchase of investments
Capital Infusion in subsidiary
Net cash inflow from disposal of subsidiary
Loans disbursed
Loans against policies
Proceeds from sale of investments
Repayments received
Advance/deposit for investment property
Interest, dividend & rent received (net of tax deducted at source)
Investments in money market instruments and in liquid mutual funds (Net)
Expenses related to investments
Net cashflow from / (used in) investing activities (B)
(8,086)
30
(8,056)
(7,802,536)
(21,043)
7,605,532
695,312
(167,449)
(1,845)
299,915
(12,104)
95
(12,009)
(14,915,253)
(3,000)
20,350
(58,715)
14,261,230
379
1,197,959
268,823
(3,383)
756,381
(6,063)
221
(5,842)
(6,800,902)
(3,000)
(30,756)
7,021,538
610,650
(123,365)
(1,855)
666,468
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of share capital3
Proceeds from borrowing
Repayments of borrowing
Interest, Dividend paid
Net cashflow from / (used in) financing activities (C)
Effect of foreign exchange rates on cash and cash equivalents (net) (D)
Net increase/(decrease) in cash and cash equivalents (A+B+C+D)
Cash and cash equivalents at beginning of the period/year
Cash and cash equivalents at end of the period/year
Note:
Cash and cash equivalents at the end of the period/year
- Cash (Including cheques in hand and stamps in hand)
- Bank Balances and Money at call and short notice4
6,634
(23,938)
(17,304)
15,099
(387)
(31,772)
(17,060)
4,870
(12,306)
(7,436)
79
30,682
992,442
1,023,124
4
204,615
787,827
992,442
1
152,826
787,827
940,653
6,223
20,506
6,878
[Including bank balance for linked business of ₹131 lakhs at September 30, 2026, ₹ 737
lakhs at March 31, 2026, ₹ 74 lakhs at September 30, 2025]
- Other short term liquid investment
[Forming part of Investments and Other Assets in Balance Sheet]
-Stamps on Hand
[Part of Cash (including cheques, drafts and stamps), however not a part of cash and
9,219
94,001
6,915
1,009,723
881,104
929,800
cash equivalents]
Cash and cash equivalents at end of the period/year
(2,041)
1,023,124
(3,169)
992,442
(2,940)
940,653
Reconciliation of Cash and cash equivalents with Cash and Bank Balance
Cash and cash equivalents
Add: Stamps on Hand
Less: Linked business bank balance
Less: Other short term liquid investment
Cash and Bank Balance
1,023,124
2,041
(131)
(1,009,723)
15,311
992,442
3,169
(737)
(881,104)
113,770
940,653
2,940
(74)
(929,800)
13,719
1
Including rewards and/or remuneration to agents, brokers or other intermediaries
2
Includes CSR expenses paid amounting to ₹ Nil lakhs during the half year ended (₹ 264 lakhs for year ended March 31, 2026; ₹ 132 lakhs for the half year ended September 30, 2025)
3
Includes movement in share application money and share issue expenses if any
4
Includes balance in dividend account which is unclaimed amounting to ₹ 12 lakhs (₹ 14 lakhs at March 31, 2026; ₹ 19 lakhs at September 30, 2025)
The above Receipts and payments account has been prepared as prescribed by the Insurance Regulatory and Development Authority of India (Actuarial, Finance and Investment Functions of Insurers) Regulations,
2024, as amended under the "Direct method" in accordance with Accounting Standard-3 Cash Flow Statements issued by the Institute of Chartered Accountants of India.
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Statement of Standalone disclosures as per Regulation 52 (4) of SEBI (Listing Obligation and Disclosure requirements) Regulations 2015, as amended,
for the quarter and half year ended September 30, 2026
Three months ended/at
Sr No. Particulars
September 30,
2026
(Unaudited)
1
2
3
4
5
6
7
8
9
Debt-Equity Ratio (No. of times) (Note 1)
June 30, 2026
(Unaudited)
Six months ended/at
Year ended/at
September 30,
September 30,
September 30,
2025
2026
2025
(Unaudited)
(Unaudited)
(Unaudited)
March 31, 2026
(Audited)
0.18
0.18
0.20
0.18
0.20
0.19
9.45
9.47
8.07
9.46
8.09
10.36
9.45
259,500
9.47
259,500
8.07
260,000
9.46
259,500
8.09
260,000
10.36
259,500
NA
NA
NA
NA
NA
NA
NA
1,463,328
37,422
NA
1,437,521
38,618
NA
1,272,725
29,926
NA
1,463,328
76,040
NA
1,272,725
60,135
NA
1,363,115
160,036
2.58
2.66
2.07
5.24
4.16
11.06
2.57
1.07
NA
NA
0.02
0.01
NA
NA
NA
NA
2.66
1.04
NA
NA
0.02
0.01
NA
NA
NA
NA
2.06
1.23
NA
NA
0.01
0.01
NA
NA
NA
NA
5.23
1.07
NA
NA
0.02
0.01
NA
NA
NA
NA
4.13
1.23
NA
NA
0.01
0.01
NA
NA
NA
NA
11.00
1.13
NA
NA
0.02
0.01
NA
NA
NA
NA
Debt Service Coverage Ratio (DSCR) (No.of times) (not
annualised except year end) (Note 2)
Interest Service Coverage Ratio (ISCR) (No.of times)
(not annualised except year end) (Note 3)
Total Borrowings
Outstanding redeemable preference share (quantity &
value)
Capital Redemption Reserve/Debenture redemption
reserve (Note 4)
Net worth (Note 5) (₹ in Lakhs)
Net Profit After Tax (₹ in Lakhs)
Earnings Per Share:
(a) Basic EPS before and after extraordinary items
(net of tax expense) for the period (not annualised
except year end)
(b) Diluted EPS before and after extraordinary items
(net of tax expense) for the period (not annualised
10
11
12
13
14
15
16
17
18
except year end)
Current ratio (Note 6)
Long term debt to working capital (Note 7)
Bad debts to Account receivable ratio (Note 7)
Current liability ratio (Note 8)
Total debts to total assets (Note 9)*
Debtors turnover (Note 7)
Inventory turnover (Note 7)
Operating margin % (Note 7)
Net profit margin % (Note 7)
Notes:
1
Debt-Equity Ratio is calculated as total borrowings divided by Equity. Equity is calculated as shareholder's funds excluding redeemable preference shares, if any.
2
DSCR is calculated as Profit before interest, depreciation and tax (Shareholders account) divided by interest expenses together with principal payments of long
term debt during the period.
3
ISCR is calculated as Profit before interest, depreciation and tax (Shareholders account) divided by interest expenses of long term debt during the period.
4
Capital Redemption Reserve and Debenture redemption reserve is not required to be created as per Companies Act, 2013 and Companies (Share Capital &
5
6
7
8
Debenture) Amendment Rules, 2019 dated August 16, 2019 respectively.
Net worth represents shareholder's funds excluding redeemable preference shares, if any.
Current ratio is computed as current assets divided by current liability.
Not applicable to insurance companies.
Current liability ratio is computed as current liability divided by total liability. Total liability includes borrowings, policyholders' liabilities, fund for future
9
10
appropriation and current liability.
Total debt to total assets is computed as borrowings divided by total assets.
Sector specific equivalent ratios are disclosed in Analytical ratios forming part of Standalone SEBI results.
*represents 0.0078 for the quarter and half year ended September 30, 2026, 0.0077 for the quarter ended June 30, 2026, 0.0080 for the quarter and half year
ended September 30, 2025, 0.0081 for the year ended March 31, 2026.
ICICI Life Insurance Limited
(Formerly known as ICICI Prudential Life Insurance Company Limited)
Other disclosures:
Status of Shareholders Complaints for the quarter ended September 30, 2026:
Sr No.
1
2
3
4
Particulars
No. of investor complaints pending at the beginning of period
No. of investor complaints received during the period
No. of investor complaints disposed off during the period
No. of investor complaints remaining unresolved at the end of the period
Number
0
0
0
0
Notes:
1
The above standalone unaudited financial results of the Company for the quarter and half year ended September 30, 2026 were
reviewed by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on October 13, 2026.
2
The above standalone unaudited financial results have been prepared in accordance with the recognition and measurement principles
laid down in Accounting Standard 25 "Interim Financial Reporting" ("AS 25") notified by the Companies (Accounting Standards) Rules,
2021, as prescribed under Section 133 of the Companies Act, 2013, the relevant provision prescribed by IRDAI (Actuarial, Finance and
Investment Functions of Insurers) Regulations, 2024, requirements of Regulation 33 and Regulation 52 read with Regulation 63(2) of
the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time, to the extent applicable
and IRDAI circular IRDAI/F&I/REG/CIR/208/10/2016 dated October 25, 2016 on publication of financial results for life insurance
i
The above standalone unaudited financial results for the quarter and half year ended September 30, 2026 were subjected to limited
review by the joint statutory auditors, M/s M. P. Chitale & Co., Chartered Accountants and M/s Chaturvedi & Co LLP, Chartered
Accountants. The financial results for the corresponding quarter and half year ended September 30, 2025 and the year ended March 31,
2026 included in these statements were reviewed and audited respectively by M/s M P Chitale & Co. (one of the current joint statutory
auditors) jointly with M/s Walker Chandiok & Co LLP, who had issued an unmodified limited review report dated October 14, 2025 and
an unmodified audit report dated April 14, 2026 respectively.
3
4
In view of seasonality of the industry, the financial results for the quarter and half year ended September 30, 2026 are not indicative of
full year's expected performance.
5
The amounts for the quarter ended September 30, 2026 are balancing amounts between the amounts as per unaudited accounts for the
half year ended September 30, 2026 and unaudited accounts for the quarter ended June 30, 2026. Similarly, the amounts for the quarter
ended September 30, 2025 are balancing amounts between the amounts as per unaudited accounts for the half year ended September
30, 2025 and unaudited accounts for the quarter ended June 30, 2025.
6
During the quarter and half year ended September 30, 2026, the Company has allotted 1,952,518 equity shares of face value of ₹ 10
each pursuant to exercise of employee stock options.
7
In furtherance of a request from Prudential Corporation Holdings Limited (PCHL) for reclassification from 'promoter' to 'investor' vide its
letter dated July 5, 2026, the Board of Directors, at its meeting held on July 6, 2026, approved a proposal to change the name of the
Company from 'ICICI Prudential Life Insurance Company Limited' to 'ICICI Life Insurance Limited' and to file an application with the
IRDAI for reclassification of PCHL from 'promoter' to 'investor'. The name change became effective on September 22, 2026, upon
issuance of a fresh Certificate of Incorporation by the Registrar of Companies. The reclassification request is currently under
consideration by IRDAI and accordingly the proposed reclassification has not been given effect to in these financial statements.
8
IRDAI, vide IRDAI (Actuarial, Finance and Investment Functions of Insurers) (Amendment) Regulations, 2026 ("Amended Regulation")
has mandated insurance companies to prepare financial statements in accordance with applicable Indian Accounting Standard (Ind AS)
w.e.f April 1, 2026. The Amended Regulation provides an option to the insurance companies to obtain a forbearance for a period of one
year with prior approval of IRDAI. Pursuant to the above, the Company has obtained approval from IRDAI for such forbearance,
permitting it to defer the adoption of Ind AS by one year. Accordingly, the Company has prepared its financial statements as per the
accounting principles generally accepted in India (Indian GAAP) and Schedule II of the IRDAI (Actuarial, Finance and Investment
Functions of Insurers) Regulations, 2024.
9
Figures of the previous period have been re-grouped wherever necessary, to conform to the current period presentation.
10
In accordance with requirements of IRDAI Circular on “Public disclosures by Insurers” dated December 31, 2021, the Company will
publish the financials on the Company’s website latest by October 28, 2026.
For and on behalf of the Board of Directors
Anup Bagchi
Managing Director & CEO
DIN: 00105962
M. P. Chitale & Co.
Chartered Accountants
1st Floor, Hamam House,
Ambalal Doshi Marg, Fort
Mumbai – 400001
Chaturvedi & Co LLP
Chartered Accountants
81, Mittal Chambers
228, Nariman Point,
Mumbai – 400 021
Independent Auditors’ Review Report on Statement of Standalone Unaudited Financial
Results of ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance
Company Limited) pursuant to Regulation 33 and Regulation 52 read with Regulation
63(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 read with Insurance Regulatory and Development
Authority of India Circular reference: IRDAI/F&I/REG/CIR/208/10/ 2016 dated 25
October 2016
To
The Board of Directors
ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance Company
Limited)
- We have reviewed the accompanying statement of standalone unaudited financial results
(the ‘Statement’) of ICICI Life Insurance Limited (Formerly ICICI Prudential Life
Insurance Company Limited) (‘the Company’) for the quarter and half year ended 30
September 2026, being submitted by the Company pursuant to requirements of
Regulation 33 and 52 read with Regulation 63(2) of the Securities and Exchange Board of
India (“SEBI”) (Listing Obligations and Disclosure Requirements) Regulation, 2015, as
amended (the “Listing Regulations”) read with Insurance Regulatory and Development
Authority of India’s (“IRDAI” / the “Authority”) Circular bearing reference no.
IRDAI/F&I/ REG/ CIR/208/10/2016 dated 25 October 2016 (“IRDAI Circular”).
- The Statement, which is the responsibility of the Company’s Management and approved
by the Company’s Board of Directors, has been prepared in accordance with the
requirements of recognition and measurement principles laid down in Accounting
Standard 25, “Interim Financial Reporting" (AS 25) notified by the Companies
(Accounting Standards) Rules, 2021, as prescribed under Section 133 of the Companies
Act, 2013 (the “Act”) and other accounting principles generally accepted in India, read
with the accounting and presentation principles as prescribed in the relevant provisions
of the Insurance Act, 1938 (the “Insurance Act”), as amended from time to time, the
Insurance Regulatory and Development Authority of India Act, 1999 (the “IRDAI Act”),
the IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024
(the “IRDAI Financial Statements Regulations”) and orders/directions/circulars issued by
the IRDAI, and has been presented in accordance with the presentation and disclosure
requirements prescribed by the IRDAI Circular and the Listing Regulations, to the extent
applicable. Our responsibility is to express a conclusion on the Statement based on our
review.
- We conducted our review of the Statement in accordance with the Standard on Review
Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the
Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of
India. This Standard requires that we plan and perform the review to obtain moderate
assurance as to whether the Statement is free from material misstatement. A review of
M. P. Chitale & Co.
Chartered Accountants
Chaturvedi & Co LLP
Chartered Accountants
Independent Auditor’s Review Report (Continued)
ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance
Company Limited)
interim financial information consists of making inquiries, primarily of persons
responsible for financial and accounting matters, and applying analytical and other review
procedures. A review is substantially less in scope than an audit conducted in accordance
with the Standards on Auditing specified under section 143(10) of the Companies Act,
2013 and consequently, does not enable us to obtain assurance that we would become
aware of all significant matters that might be identified in an audit. Accordingly, we do not
express an audit opinion.
4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our
attention that causes us to believe that the accompanying Statement prepared in
accordance with the requirements of the recognition and measurement principles laid
down in AS 25 notified by the Companies (Accounting Standards) Rules, 2021,
prescribed under Section 133 of the Act and other accounting principles generally
accepted in India, read with the accounting and presentation principles as prescribed in
the relevant provisions of the Insurance Act, the IRDAI Act and IRDAI Financial
Statements Regulations and orders/directions/circulars issued by the IRDAI, to the extent
applicable, has not presented and disclosed the information required to be disclosed in
terms of the IRDAI Circular and the Listing Regulations, including the manner in which
it is to be disclosed or that it contains any material misstatement.
Emphasis of Matter
5. We draw attention to Note No 8 which states that the company has prepared its financial
statements as per the accounting principles generally accepted in India (Indian GAAP)
and Schedule II of the IRDAI (Actuarial, Finance and Investment Functions of Insurers)
Regulations, 2024 pursuant to forbearance received from IRDAI, permitting it to defer
the adoption of Ind AS for a period of one year.
Our conclusion is not modified in respect of this matter.
Other Matter
6. The actuarial valuation of liabilities for life policies in force and for policies in respect of
which premium has been discontinued but liability exists as at 30 September 2026 is the
responsibility of the Company’s Appointed Actuary (the ‘Appointed Actuary’). The
actuarial valuation of these liabilities for life policies in force and for policies in respect
of which premium has been discontinued but liability exists as at 30 September 2026 has
been duly certified by the Appointed Actuary, and in his opinion, the assumptions for
such valuation are in accordance with the guidelines, norms and regulations issued by the
IRDAI and the Institute of Actuaries of India in concurrence with the Authority.
Accordingly, we have relied upon the Appointed Actuary’s certificate in this regard for
forming our conclusion on the valuation of liabilities for life policies in force and for
policies in respect of which premium has been discontinued but liability exists, as
contained in the Statement of the Company.
M. P. Chitale & Co.
Chartered Accountants
Chaturvedi & Co LLP
Chartered Accountants
Independent Auditor’s Review Report (Continued)
ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance
Company Limited)
7. The unaudited Standalone Financial Results for the corresponding quarter and half year
ended 30 September 2025 and the audited Standalone Financial Results for the year
ended 31 March 2026, included in the accompanying Standalone Financial results were
reviewed/audited by M.P. Chitale & Co, one of the current joint auditors of the Company,
jointly with Walker Chandiok & Co LLP, who had jointly expressed an unmodified
conclusion/opinion vide their review report dated 14 October 2025 and audit report dated
14 April 2026 respectively, and these reports have been furnished to and relied upon by
Chaturvedi & Co LLP, one of the other current joint auditors, for the purpose of their
joint review of the unaudited Standalone Financial Results.
Our conclusion is not modified in respect of these matters.
For M. P. Chitale & Co.
Chartered Accountants
ICAI FRN: 101851W
For Chaturvedi & Co LLP
Chartered Accountants
ICAI FRN:302137E/E300286
Harnish Shah
Partner
Membership No: 145160
S S N Chaturvedi
Partner
Membership No: 040479
UDIN: 26145160YPQMLQ8685
UDIN: 26040479AQCELE1858
Place: Mumbai
Date: 13 October 2026
Place: Mumbai
Date: 13 October 2026
October 13, 2026
Performance for the half year ended September 30, 2026
- Key updates
The Company has been renamed to ‘ICICI Life Insurance Limited’ marking an important milestone
in its 25-year journey. With the renewed brand identity and a strong financial position, the
Company remains well-placed to enhance customer outcomes, drive sustainable growth, and
deliver long-term value for all its stakeholders.
- Operating performance review
₹ in billion
H1-FY2026
Profit/(Loss) After Tax (PAT)
Value of New Business (VNB)
VNB Margin
Embedded Value
New business received premium
Total premium
Annualised Premium Equivalent (APE)
-Savings APE
-Annuity APE
-Protection APE
New business sum assured (₹ trn)
Retail new business sum assured (₹ trn)
Total in-force sum assured (₹ trn)
Cost/Total premium
Cost/Total premium ex-GST
Savings Cost/Total premium
Savings Cost/Total premium ex-GST
Solvency
Net worth
Assets under management (₹ trn)
6.01
10.49
24.5%
505.01
94.56
212.51
42.86
32.42
2.16
8.28
6.77
1.72
42.16
19.2%
18.6%
12.7%
12.5%
213.2%
127.27
3.21
FY2026
16.00
26.29
24.7%
529.89
248.10
531.25
106.41
81.23
6.13
19.06
14.50
4.50
46.11
18.2%
16.7%
12.1%
11.0%
227.3%
136.31
3.14
H1-FY2027
7.60
12.83
26.0%
566.69
118.21
245.05
49.35
34.55
3.24
11.55
8.81
2.32
49.92
20.0%
18.3%
12.7%
11.6%
229.9%
146.33
3.29
Y-o-Y
26.5%
22.3%
150 bps
12.2%
25.0%
15.3%
15.1%
6.6%
50.0%
39.5%
30.1%
34.9%
18.4%
80 bps
(30 bps)
(90 bps)
16.7%
15.0%
2.3%
Total cost including commission excluding interest on sub debt/Total premium
Y-o-Y: Year-on-year
Persistency
13th month
25th month
37th month
49th month
61st month
12-month rolling persistency
Regular and limited pay
March 31, 2026
June 30, 2026
September 30, 2026
84.5%
84.0%
84.5%
81.0%
77.0%
76.2%
76.3%
77.3%
77.0%
71.8%
71.7%
71.6%
61.6%
61.9%
62.5%
• Profitability
Value of new business (VNB) grew by 22.3% year-on-year from ₹ 10.49 billion in H1-FY2026 to ₹
12.83 billion in H1-FY2027, with a margin of 26.0%.
The Company’s PAT grew by 26.5% year-on-year from ₹ 6.01 billion in H1-FY2026 to ₹ 7.60 billion
in H1-FY2027, primarily driven by higher Shareholders’ investment income and improved surplus
generation in policyholders’ in-force book.
• Embedded Value
The Company’s EV grew by 12.2% year-on-year from ₹ 505.01 billion at September 30, 2025 to ₹
566.69 billion at September 30, 2026. The Value of In-force (VIF) book grew by 12.0% year-on-year
from ₹ 378.40 billion at September 30, 2025 to ₹ 423.89 billion at September 30, 2026.
• Premium
New business received premium grew by 25.0% year-on-year from ₹ 94.56 billion in H1-FY2026 to
₹ 118.21 billion in H1-FY2027. APE grew by 15.1% year-on-year from ₹ 42.86 in H1-FY2026 to ₹
49.35 in H1-FY2027 on the back of 10.6% year-on-year growth in the number of policies reflecting
the continued expansion of customer base. Savings APE stood at ₹ 37.79 billion and overall
protection APE stood at ₹ 11.55 billion.
The overall protection APE registered a strong growth of 39.5% year-on-year in H1-FY2027 driven
by growth across retail and group protection. Retail protection APE grew by 47.2% year on-year
from ₹ 3.09 billion in H1-FY2026 to ₹ 4.55 billion in H1-FY2027. Consequently, in H1-FY2027, sum
assured grew by 30.1% year-on-year to ₹ 8.81 trillion and sum assured market share stood at
11.5%. Retail sum assured increased by 34.9% year-on-year to ₹ 2.32 trillion in H1-FY2027.
Total in-force sum assured, which is the quantum of life cover taken by customers of the Company
stood at ₹ 49.92 trillion at September 30, 2026.
• Product mix
The Company offers a wide range of products across various segments such as savings (linked and
non-linked), annuity and protection to meet the evolving needs of the customers. The Company has
a well-diversified product mix with H1-FY2027 APE contribution from linked, non-linked, protection,
annuity, and group funds at 44.5%, 18.1%, 23.4%, 6.6% and 7.4% respectively.
• Cost efficiency
Over the last few years, the Company has leveraged technology, digital & AI initiatives to improve
productivity while making the cost structure leaner and aligned to the prevailing product mix. As a
result of these initiatives, cost to premium ratio excluding GST reduced by 30 bps year-on-year to
18.3% in H1-FY2027. Savings cost to premium ratio excluding GST reduced by 90 bps year-on-year
to 11.6% in the same period. Including GST, cost to premium ratio increased by 80 bps year-on-year
to 20.0% in H1-FY2027 and savings cost to premium ratio remained stable at 12.7% in the same
period.
• Persistency
The 13th month and 49th month persistency ratio stood at 84.5% and 71.6% respectively at
September 30, 2026.
• Assets under management
The assets under management of the Company stood at ₹ 3.29 trillion at September 30, 2026. The
Company has a debt-equity mix of 59:41, and 95.2% of the fixed income investments are in
sovereign or AAA rated instruments. The Company has zero Non-Performing Assets (NPA) since
inception, indicating high quality of the asset book.
• Net worth and capital position
The Company’s net worth was ₹ 146.33 billion at September 30, 2026. The solvency ratio was
229.9% against the regulatory requirement of 150%.
- Financial performance review
Summary Standalone Revenue and Profit & Loss Account
Particulars
Premium earned
Premium on reinsurance
ceded
Premium on reinsurance
accepted
Net premium earned
Investment income1
Unit-linked
Other than unit-linked
Other income
Total income
Commission paid2
Expenses3
Interest on Non-convertible
Debentures
Tax on policyholders fund
Claims/benefits paid4
Change in actuarial liability5
Total Outgo
Profit/(Loss) before tax
Tax charge/ (credit)
Profit/(Loss) after tax
Three months ended
(₹ in billion)
Year
Six months ended
ended
September September March 31,
30, 2026
30, 2025
2026
245.05
212.51
531.25
(9.52)
(9.05)
(17.89)
September
30, 2026
142.55
(4.51)
June 30,
2026
102.51
(5.01)
September
30, 2025
122.97
(4.54)
138.04
(17.73)
(46.67)
28.95
0.68
121.00
13.76
12.94
0.52
97.49
187.63
157.53
30.11
1.25
286.37
10.14
12.34
0.51
118.43
0.92
(27.37)
28.29
0.58
119.93
12.04
11.24
0.49
235.53
169.91
110.86
59.05
1.93
407.37
23.90
25.28
1.02
203.46
169.84
113.58
56.26
1.11
374.41
21.48
22.47
0.98
513.36
120.71
9.18
111.53
2.31
636.37
51.81
48.26
1.93
0.10
129.24
(39.91)
116.64
4.35
0.61
3.74
0.38
89.50
169.19
282.06
4.31
0.45
3.86
0.47
112.77
(20.55)
116.46
3.47
0.47
2.99
0.49
218.74
129.28
398.70
8.67
1.06
7.60
0.94
210.39
111.23
367.49
6.92
0.90
6.01
(2.53)
471.99
46.84
618.30
18.07
2.06
16.00
- Net of provision for diminution in value of investments
- Commission also includes rewards and/or remuneration to agents, brokers or other intermediaries
- Includes provisions for doubtful debts (including write off) and goods and service tax on linked charges
- Net of reinsurance
- Includes movement in funds for future appropriation
Components may not add up to the totals due to rounding off
The Company’s profit before tax increased from ₹ 6.92 billion in H1-FY2026 to ₹ 8.67 billion in H1-FY2027
primarily driven by higher shareholders’ investment income and improved surplus generation in
policyholders’ in-force book. Profit after tax have increased from ₹ 6.02 billion in H1-FY2026 to ₹ 7.60
billion in H1-FY2027, a year-on-year growth of 26.5%.
The performance highlights for H1-FY2027 are as given below:
•
Net premium earned (gross premium less reinsurance premium) increased by 15.8% from ₹ 203.46
billion in H1-FY2026 to ₹ 235.53 billion in H1-FY2027.
•
Total investment income marginally increased from ₹ 169.84 billion in H1-FY2026 to ₹ 169.91 billion
in H1-FY2027. The movement was driven by the following:
• Investment income under unit-linked decreased marginally from ₹ 113.58 billion in H1-FY2026
to ₹ 110.86 billion in H1-FY2027. Investment income under unit-linked is directly offset by the
change in valuation of policyholder liabilities.
• Investment income under other than unit-linked increased from ₹ 56.26 billion in H1-FY2026 to
₹ 59.05 billion in H1-FY2027 primarily on account of increase in interest income and dividend.
• Total expenses (including commission) increased by 11.7% from ₹ 44.93 billion in H1-FY2026 to ₹
50.20 billion in H1-FY2027. Commission expenses increased by 11.2% from ₹ 21.48 billion in H1FY2026 to ₹ 23.90 billion in H1-FY2027 in line with growth in premium income and product mix.
Operating expense increased by 12.5% from ₹ 22.47 billion in H1-FY2026 to ₹ 25.28 billion in H1FY2027. Operating expenses include unit fund expenses (including goods and service tax on linked
charges) amounting to ₹ 0.29 billion (H1-FY2026: ₹ 3.33 billion) under the unit-linked portfolio. The
unit fund expenses under the unit-linked portfolio are directly offset by changes in the valuation of
policyholder liabilities. Operating expenses of other than unit-linked portfolio increased by 30.6%
from ₹ 19.14 billion in H1-FY2026 to ₹ 24.99 billion in H1-FY2027, primarily on account of higher
GST expenses emanating from disallowance of input tax credit on retail business coupled with
increase in business support, development expenses and wage cost.
•
Claims and benefit payouts (net of reinsurance) increased by 4.0% from ₹ 210.39 billion in H1FY2026 to ₹ 218.74 billion in H1-FY2027 primarily on account of increase in maturity claims partly
offset by decrease in Surrender claims.
•
Change in actuarial liability, including funds for future appropriation and fund reserve, increased
from ₹ 111.23 billion in H1-FY2026 to ₹ 129.28 billion in H1-FY2027. Change in fund reserve, which
represents change in liability carried on account of units held by unit-linked policyholders, increased
from ₹ 43.34 billion in H1-FY2026 to ₹ 74.32 billion in H1-FY2027 primarily on account of lower
benefits outgo coupled with higher premium income. Non-unit reserves, including funds for future
appropriation, decreased from ₹ 67.89 billion in H1-FY2026 to ₹ 54.96 billion in H1-FY2027.
Disclaimer
Except for the historical information contained herein, statements in this release which contain words or phrases such as 'will',
‘expected to’, etc., and similar expressions or variations of such expressions may constitute 'forward-looking statements'.
These forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual results,
opportunities and growth potential to differ materially from those suggested by the forward-looking statements. These risks
and uncertainties include, but are not limited to, the actual growth in demand for insurance and other financial products and
services in the countries that we operate or where a material number of our customers reside, our ability to successfully
implement our strategy, including our use of the Internet and other technology, our exploration of merger and acquisition
opportunities, our ability to integrate mergers or acquisitions into our operations and manage the risks associated with such
acquisitions to achieve our strategic and financial objectives, our growth and expansion in domestic and overseas markets,
technological changes, our ability to market new products, the outcome of any legal, tax or regulatory proceedings in India
and in other jurisdictions we are or become a party to, the future impact of new accounting standards, our ability to implement
our dividend policy, the impact of changes in insurance regulations and other regulatory changes in India and other
jurisdictions on us. ICICI Life Insurance (Formerly known as ICICI Prudential Life Insurance Company Limited) undertakes no
obligation to update forward-looking statements to reflect events or circumstances after the date thereof.
This release does not constitute an offer of securities.
For investor queries please reach out to Investor relations team at +91-22-40391600 or email [email protected].
1 billion = 100 crore
News Release
October 13, 2026
NSE Code: ICICIPRULI
BSE Code: 540133
ICICI Life reports robust PAT growth of 26.5% to
₹ 760 crore in H1-FY2027
Highlights:
•
Company renamed to ‘ICICI Life Insurance Limited’
•
Profit after tax grew by 26.5% year-on-year to ₹ 760 crore in H1-FY2027
•
Value of new business (VNB) grew strongly by 22.3% year-on-year to ₹ 1,283 crore
in H1-FY2027, with a margin of 26.0%
•
Retail New Business Sum Assured grew by 34.9% year-on-year to ₹ 2.32 lakh crore
in H1-FY2027
•
Retail protection APE registered strong growth of 47.2% year-on-year & Annuity
APE grew strongly by 50.0% year-on-year in H1-FY2027
Mumbai, October 13, 2026: The Board of Directors of ICICI Life Insurance Limited
approved and adopted the financial results for the quarter ended September 30, 2026.
The Company has been renamed to ‘ICICI Life Insurance Limited’, marking an important
milestone in its 25-year journey of securing dreams and financial future of more than 20
crore Indians. As this new chapter unfolds, the Company’s commitment of making ‘Har Kal
Aasaan’ for all its stakeholders continues to be guided by its customer-first philosophy.
Thus, reflecting the Company’s broader commitment to make the experience of securing
one’s financial future simpler, more transparent, more flexible and with ease.
The Company continues to focus on protection and annuity segments representing the
under-served needs of Indians. In H1-FY2027, the retail protection segment grew by 47.2%
year-on-year and the annuity segment grew by 50.0% year-on-year. As a result, retail sum
assured increased by 34.9% year-on-year to ₹ 2.32 lakh crore, reflecting a meaningful
expansion in the coverage offered to customers. The Company’s flagship term plan,
iProtect Smart Plus, has been awarded ‘Product of the Year 2026-27’ through NielsenIQ’s
consumer research, a reflection of its commitment to launch innovative and customercentric products.
H1-FY2027 was marked by a challenging macro environment. Despite the external
volatility, the Company’s resilient performance was backed by its well-diversified
distribution network, customer-centric products & processes, industry leading quality
parameters, and strong risk & capital metrics. New business premium grew by 25.0%
year-on-year to ₹ 11,821 crore in H1-FY2027. Value of New Business (VNB) grew by
Page 1 of 5
22.3% year-on-year to ₹ 1,283 crore, with a margin of 26.0%. Profit After Tax (PAT)
increased by 26.5% year-on-year to ₹ 760 crore in H1-FY2027. Embedded Value (EV)
stood at ₹ 56,669 crore, reflecting a year-on-year growth of 12.2%, and the Value of
in-force business (VIF) stood at ₹ 42,389 crore registering a growth of 12.0% year-on-year.
Company continues to leverage economies of scale, technology, Artificial Intelligence (AI),
and digital capabilities to improve efficiency and enhance customer experience. The
Company issued 54% of its savings policies on the same day in H1-FY2027. Cost-topremium ratio excluding GST reduced by 30 bps year-on-year to 18.3% in H1-FY2027 and
savings cost-to-premium ratio excluding GST reduced by 90 bps year-on-year to 11.6% in
the same period.
The Company’s claim settlement ratio stood at 99.3% in H1-FY2027, with an average
turnaround time of 1.1 days for non-investigated claims. During the period, the Company
settled ₹ 2,627 crores of death claims and paid ₹ 8,634 crores as maturity and survival
benefits, reflecting its continued focus on delivering timely financial protection and peace
of mind to customers when needed the most.
Mr. Sidharatha Mishra, Chief Operating Officer (COO) of ICICI Life Insurance Limited
said, “Customer centricity has always been ICICI Life’s core ethos, and this steadfast
commitment will continue to guide all our actions in the years ahead as well. Protection
and annuity remain at the heart of our long-term strategy, addressing deeply
underpenetrated needs in India. Backed by a well-diversified distribution network,
innovative & customer-centric product portfolio, customer-first sales & service, industry
leading quality parameters, strong risk & capital metrics, we are a resilient organisation
that can successfully capitalise on emerging opportunities. Our commitment is to deliver
sustainable VNB growth while balancing business, profitability and risk & prudence.”
Key performance highlights:
▪
Premium: New business received premium grew by 25.0% year-on-year from ₹ 9,456
crore in H1-FY2026 to ₹ 11,821 crore in H1-FY2027. Annualised Premium Equivalent
(APE) grew by 15.1% year-on-year from ₹ 4,286 crore in H1-FY2026 to ₹ 4,935 crore
in H1-FY2027. The overall protection APE registered a growth of 39.5% year-on-year
in H1-FY2027. Retail protection APE grew by 47.2% year-on-year from ₹ 309 crore in
H1-FY2026 to ₹ 455 crore in H1-FY2027. Annuity APE grew by 50.0% year-on-year
from ₹ 216 crore in H1-FY2026 to ₹ 324 crore in the same period.
▪
Sum assured: Retail new business sum assured grew strongly by 34.9% year-on-year
to ₹ 2.32 lakh crore in H1-FY2027. The total in-force sum assured, which is the
quantum of life cover taken by customers of the Company, grew by 18.4% year-onyear from ₹ 42.16 lakh crore at September 30, 2025, to ₹ 49.92 lakh crore at September
30, 2026.
Page 2 of 5
▪
Cost: Cost to premium ratio (without GST) reduced by 30 bps year-on-year to 18.3%
in H1-FY2027. Savings cost to premium ratio (without GST) reduced by 90 bps yearon-year to 11.6% in the same period. Including GST, cost to premium ratio increased
by 80 bps year-on-year to 20.0% in H1-FY2027 and savings cost to premium ratio
remained stable at 12.7% in the same period.
▪
Profitability: The Value of New Business (VNB) grew by 22.3% year-on-year and stood
at ₹ 1,283 crore with a margin of 26.0% in H1-FY2027. Profit after tax (PAT) grew by
26.5% year-on-year from ₹ 601 crore in H1-FY2026 to ₹ 760 crore in H1-FY2027.
▪
Embedded Value: EV grew by 12.2% year-on-year to ₹ 56,669 crore and Value of Inforce business (VIF) grew by 12.0% year-on-year to ₹ 42,389 crore as on September
30, 2026.
▪
Claim Settlement Ratio: Claim settlement ratio stood at 99.3% with an average
turnaround time of 1.1 day for non-investigated individual death claims in H1-FY2027.
▪
Persistency: 13th month and 49th month persistency stood at 84.5% and 71.6%
respectively in H1-FY2027.
▪
Solvency Ratio: Solvency ratio stood at 229.9% as on September 30, 2026, against the
regulatory requirement of 150%.
▪
Assets under Management (AUM): AUM stood at ₹ 3.29 lakh crore as on September
30, 2026.
▪
ESG: The Company continues to retain one of the highest rankings in the Indian life
insurance industry as per leading global and Indian ESG rating agencies.
Financial metrics:
` crore
H1-FY2026
H1-FY2027
Y-o-Y
Profit After Tax (PAT)
601
760
26.5%
Value of New Business (VNB)
1,049
1,283
22.3%
VNB Margin
24.5%
26.0%
150 bps
Embedded Value
50,501
56,669
12.2%
New Business Received Premium
9,456
11,821
25.0%
Total Premium
21,251
24,505
15.3%
Annualised Premium Equivalent (APE)
4,286
4,935
15.1%
• Savings
3,242
3,455
6.6%
• Annuity
216
324
50.0%
• Protection
828
1,155
39.5%
Page 3 of 5
` crore
H1-FY2026
H1-FY2027
Y-o-Y
Product mix (% of APE): Linked/nonlinked/annuity/protection/group funds
48/22/5/19/6
45/18/7/23/7
25/14/30/13/18
22/14/27/15/22
1.72
2.32
34.9%
6.77
8.81
30.1%
Channel mix (% of APE):
Agency/direct/ banca/partnership
distribution/group
Retail NB Sum Assured (₹ lakh crore)
NB Sum Assured (₹ lakh crore)
Total in-force sum assured (₹ lakh
crore)
Cost/Total premium
42.16
49.92
18.4%
19.2%
20.0%
80 bps
Cost/Total premium ex-GST
18.6%
18.3%
(30 bps)
Savings Cost/Total premium
12.7%
12.7%
Savings Cost/Total premium ex-GST
12.5%
11.6%
(90 bps)
Solvency
Assets under Management (AUM) (₹
lakh crore)
213.2%
229.9%
16.7%
3.21
3.29
2.3%
Components may not add up to the totals due to rounding off
Total cost including commission excluding interest on sub-debt/ Total premium
Y-o-Y: year-on-year
Definitions, abbreviations and explanatory notes
• Annual Premium Equivalent (APE): APE is a measure of new business written by a life
insurance company. It is computed as the sum of annualised first year premiums on regular
premium policies, and ten percent of single premiums, written by the Company during any period
from new retail and group customers.
• Retail Weighted Received Premium (RWRP): RWRP is a new business measure very similar to
APE for the retail (also referred to as individual) business with the only difference being that the
regular premiums considered here are first year premiums actually received by the life insurer
and not annualised. It is the sum of all retail first year premiums and ten percent of retail single
premiums received in a period.
• New Business Received Premium: It is a measure of the new business generated during the
period and reflects the total inflow of premium from newly acquired retail plus group policies.
•
Sum assured: The amount that an insurer agrees to pay upon the occurrence of a stated
contingency, in accordance with the terms and conditions of the policy.
•
Persistency: It is the most common parameter for quality of business representing the
percentage of retail policies (where premiums are expected) that continue paying premiums.
Regular and Limited pay persistency in accordance with IRDAI Master circular on Submission of
Returns 2024 dated June 14, 2024.
•
Cost Ratio: Cost ratio is a measure of the cost efficiency of a Company. It is calculated as a ratio
of expenses incurred by the Company on new business as well as renewal premiums excluding
interest on sub-debt to total premium.
Page 4 of 5
• Value of New Business (VNB) and VNB margin: VNB is used to measure profitability of the new
business written in a period. It is present value of all future profits to shareholders measured at
the time of writing of the new business contract. Future profits are computed on the basis of
long-term assumptions which are reviewed annually. VNB is also referred to as NBP (new
business profit). VNB margin is computed as VNB for the period/APE for the period. It is similar
to profit margin for any other business.
•
Embedded Value (EV): EV represents the present value of shareholders’ interests in the earnings
distributable from the assets allocated to the business after sufficient allowance for the
aggregate risks in the business.
For further press queries email us on [email protected]
About ICICI Life Insurance Limited:
ICICI Life Insurance Limited (Formerly ICICI Prudential Life Insurance Company Limited) commenced operations in FY2001
and has since established itself as one of India’s leading life insurers, consistently ranking high on both sum assured market
share and new business premium market share. Over the years, it has earned the unwavering trust of millions of customers,
becoming an integral part of India’s financial ecosystem.
Customer centricity has remained the foundation of its philosophy, with products, processes and distribution strategies all
aligned to a single objective: delivering a strong and differentiated value proposition for customers. The Company offers a
comprehensive suite of Protection, Savings & Retirement solutions designed to meet the evolving life stage needs. These
offerings enable customers to safeguard their families’ financial security while also achieving long term financial goals.
As on March 31, 2026, the Company protects 73.73 million lives (in-force) across India covering both individual and corporate
segments, making it one of the leading insurance companies in the country. Over the years, the Company has delivered on
its promise of financial protection by settling ₹ 279 billion in death claims and paying ₹ 3.72 trillion in overall benefits as of
March 31, 2026. In FY2026 alone, it settled ₹ 51.49 billion in death claims and disbursed ₹ 153.63 billion in maturity and
survival benefits. Its claim settlement ratio of 99.3 percent and average turnaround time of 1 day underscore its commitment
to swift, reliable service.
The Company is also the first among Indian Insurance industry to get listed on both the NSE and BSE. Its continued
investments in data analytics and digitisation across the policy lifecycle have enabled superior efficiency, innovation and
seamless experiences for customers and distributors alike.
Disclaimer
Except for the historical information contained herein, statements in this release which contain words or phrases such as
'will', ‘expected to,’ etc., and similar expressions or variations of such expressions may constitute 'forward-looking
statements'. These forward-looking statements involve a number of risks, uncertainties and other factors that could cause
actual results, opportunities and growth potential to differ materially from those suggested by the forward-looking
statements. These risks and uncertainties include, but are not limited to, the actual growth in demand for insurance and
other financial products and services in the countries that we operate or where a material number of our customers reside,
our ability to successfully implement our strategy, including our use of the Internet and other technology, our exploration of
merger and acquisition opportunities, our ability to integrate mergers or acquisitions into our operations and manage the
risks associated with such acquisitions to achieve our strategic and financial objectives, our growth and expansion in
domestic and overseas markets, technological changes, our ability to market new products, the outcome of any legal, tax or
regulatory proceedings in India and in other jurisdictions we are or become a party to, the future impact of new accounting
standards, our ability to implement our dividend policy, the impact of changes in insurance regulations and other regulatory
changes in India and other jurisdictions on us. The Company undertakes no obligation to update forward-looking statements
to reflect events or circumstances after the date thereof. This release does not constitute an offer of securities.
Page 5 of 5
Disclosure on Related Party Transactions for the half year ended September 30, 2026
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was
undertaken.
Details of the party (listed
entity /subsidiary)
Details of the counterparty
entering into the
transaction
Relationship of the counterparty
Name
Name
Type of related party
Details of other related
transaction
party transaction
Value of the related party
transaction as approved
by the audit committee
Remarks on approval by
audit committee
Value of the related party
Date of Audit Committee
Value of transaction
transaction ratified by the
Meeting where the
during the reporting
audit committee
ratification was approved
period
In case monies are due to either party as a result of
In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or
the transaction
investments
Nature of indebtedness
with the listed entity or its
Opening balance
Closing balance
subsidiary
ICICI Life Insurance
ICICI Bank Limited
Holding Company
Any other transaction
Premium Income
323012.7 Within Omnibus Limit
6641.03
-45.67
-107.62 NA
Cost
indebtedness
any other etc.)
NA
Details of the loans, inter-corporate deposits, advances or investments
Purpose for which the funds
Nature (loan/ advance/
Details of other
(loan/ issuance of debt/
Tenure
intercorporate deposit/
Interest Rate (%)
Tenure
Secured/ unsecured
investment)
NA
NA
NA
will be utilised by the
ultimate recipient of funds
Notes
(endusage)
NA
NA
NA
NA
Company Limited
A) Approvals taken from Audit Committee for actual amount. Value of related
party transaction approved by the audit committee denotes omnibus limit.
B) Omnibus approval limit taken is applicable at entitiy level.
ICICI Life Insurance
ICICI Bank Limited
Holding Company
Any other transaction
Benefits paid
Within Omnibus Limit
-1973.44
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Company Limited
A) Approvals taken from Audit Committee for actual amount. Value of related
party transaction approved by the audit committee denotes omnibus limit.
B) Omnibus approval limit taken is applicable at entitiy level.
ICICI Life Insurance
ICICI Bank Limited
Holding Company
Any other transaction
ICICI Bank Limited
Holding Company
Any other transaction
Within Omnibus Limit
156.87
9.23
5.17 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
2.64
1.27
0.47 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Company Limited
ICICI Life Insurance
Company Limited
ICICI Life Insurance
cost
ICICI Bank Limited
Holding Company
Any other transaction
ICICI Bank Limited
Holding Company
Any other transaction
Company Limited
Within Omnibus Limit
7.00
2.95
4.13 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
-177.15
-91.10
-114.58 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
-10.64
-3.39
-2.95 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
-77.85
0.00
90.73 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
remuneration and welfare
benefits
ICICI Life Insurance
Company Limited
ICICI Life Insurance
- Information technology
cost
ICICI Bank Limited
Holding Company
Any other transaction
Company Limited
- Employees'
remuneration and welfare
benefits
ICICI Life Insurance
ICICI Bank Limited
Holding Company
Any other transaction
Company Limited
ICICI Life Insurance
- Legal and Professional
Charges
ICICI Bank Limited
Holding Company
Any other transaction
Commission Expenses
Within Omnibus Limit
-13633.15
-1070.60
-728.06 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
ICICI Bank Limited
Holding Company
Any other transaction
Bank Charges
Within Omnibus Limit
-128.37
-27.54
-41.31 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
ICICI Bank Limited
Holding Company
Any other transaction
Trademark Usage Fees
Within Omnibus Limit
-806.15
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
ICICI Bank Limited
Holding Company
Investment
-57338.84
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Company Limited
ICICI Life Insurance
Company Limited
ICICI Life Insurance
Company Limited
ICICI Life Insurance
1500000 extended limit approved
Company Limited
ICICI Life Insurance
by Shareholders
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
ICICI Bank Limited
Holding Company
Any other transaction
Security Deposit
Within Omnibus Limit
0.00
-153.79
-153.79 NA
NA
NA
NA
NA
NA
NA
NA
NA
ICICI Bank Limited
ICICI Bank Limited
Holding Company
Holding Company
Any other transaction
Investment
Cash and Bank Balances
1500000 extended limit approved
Within Omnibus Limit
0.00
76874.52
-4432.31 NA
NA
NA
NA
NA
NA
NA
NA
NA
Company Limited
ICICI Life Insurance
2757.13
0.00
by Shareholders
Omnibus approval limit taken is applicable at entitiy level.
Company Limited
ICICI Life Insurance
Company Limited
A) Approvals taken from Audit Committee for actual amount. Value of related
party transaction approved by the audit committee denotes omnibus limit.
B) Omnibus approval limit taken is applicable at entitiy level.
ICICI Life Insurance
ICICI Securities Limited
Fellow subsidiary
Any other transaction
323012.7 Within Omnibus Limit
12.58
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
ICICI Securities Limited
Fellow subsidiary
Any other transaction
Commission Expenses
Within Omnibus Limit
-526.75
-111.24
-60.19 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
ICICI Securities Limited
Fellow subsidiary
Any other transaction
Brokerage
Within Omnibus Limit
-142.64
-1.92
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Omnibus approval limit taken is applicable at entitiy level.
ICICI Venture Funds
Fellow subsidiary
Any other transaction
323012.7 Within Omnibus Limit
-1.58
-0.57
-2.70 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Fellow subsidiary
Any other transaction
Within Omnibus Limit
0.00
0.53
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
323012.7 Within Omnibus Limit
238.36
-327.46
-21.11 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
-367.78
-71.06
-103.52 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
323012.7 Within Omnibus Limit
9.19
-2.38
-1.89 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
-106843.61
-14043.90
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
39693.94
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Company Limited
ICICI Life Insurance
Company Limited
ICICI Life Insurance
Company Limited
ICICI Life Insurance
Company Limited
Management Company
ICICI Life Insurance
ICICI Venture Funds
Company Limited
Management Company
Premium Income
Limited
Limited
ICICI Life Insurance
ICICI Home Finance
Company Limited
Company Limited
ICICI Life Insurance
ICICI Home Finance
Company Limited
Company Limited
ICICI Life Insurance
ICICI Securities Primary
Company Limited
Dealership Limited
ICICI Life Insurance
ICICI Securities Primary
Company Limited
Dealership Limited
ICICI Life Insurance
ICICI Securities Primary
Company Limited
Dealership Limited
ICICI Life Insurance
ICICI Investment
Company Limited
Management Company
- Employees'
remuneration and welfare
benefits
Fellow subsidiary
Any other transaction
Premium Income
Fellow subsidiary
Any other transaction
Commission Expenses
Fellow subsidiary
Any other transaction
Premium Income
Fellow subsidiary
Investment
1500000 extended limit approved
Fellow subsidiary
Investment
1500000 extended limit approved
Fellow subsidiary
Any other transaction
Premium Income
323012.7 Within Omnibus Limit
0.00
-0.66
-12.39 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Fellow subsidiary
Any other transaction
Premium Income
323012.7 Within Omnibus Limit
308.33
-24.24
(55) NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Fellow subsidiary
Any other transaction
Benefits paid
Within Omnibus Limit
-204.36
NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Fellow subsidiary
Any other transaction
Within Omnibus Limit
0.90
NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
NA
NA
NA
NA
Investment
NA
NA
NA
Investement Purpose
Omnibus approval limit taken is applicable at entitiy level.
NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
by Shareholders
by Shareholders
Limited
ICICI Life Insurance
ICICI Prudential Asset
Company Limited
Management Company
ICICI Life Insurance
ICICI Prudential Asset
Company Limited
Management Company
Limited
Limited
ICICI Life Insurance
ICICI Prudential Asset
Company Limited
Management Company
ICICI Life Insurance
ICICI Prudential Asset
Company Limited
Management Company
0.00
Limited
benefits
0.00
Fellow subsidiary
Investment
Within Omnibus Limit
0.00
Fellow subsidiary
Dividend received
Within Omnibus Limit
2.41
Limited
ICICI Life Insurance
ICICI Prudential Asset
Company Limited
Management Company
0.00
remuneration and welfare
534.39
Limited
0.53
884.99
ICICI Life Insurance
ICICI Prudential Trust
Fellow subsidiary
Any other transaction
Premium Income
323012.7 Within Omnibus Limit
0.12
0.00
-0.13
Company Limited
Limited
ICICI Life Insurance
India Infradebt Limited
Promoter Group
Any other transaction
Premium Income
323012.7 Within Omnibus Limit
0.94
0.00
0.00
-0.13 NA
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
India Infradebt Limited
Promoter Group
Any other transaction
Interest Income on
Within Omnibus Limit
1711.54
1079.97
1076.80 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
India Infradebt Limited
Promoter Group
Investment
Within Omnibus Limit
10000.00
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
India Infradebt Limited
Promoter Group
Investment
Within Omnibus Limit
0.00
34977.50
Investment made in Fully
7.92%
1991 days
Secured
The proceeds shall be utilized
Omnibus approval limit taken is applicable at entitiy level.
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Company Limited
ICICI Life Insurance
Company Limited
ICICI Life Insurance
Investement
Company Limited
ICICI Life Insurance
Company Limited
44961.24 Issuance of debt
7.92% India Infradebt
Limited Secured Tranche I
2,000,002,002.00 1991 days
redeemable, secured,
by the recipient towards
Series I Debentures
listed, non-convertible
financing or takeout
December 2031
Debentures
financing of Infrastructure
projects and for such other
purposes, including
towards other financing and
general business purposes of
the issuer including towards
investments for liquidity and
statutory requirements and
retire / replace existing
liabilities.
Disclosure on Related Party Transactions for the half year ended September 30, 2026
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was
undertaken.
Details of the party (listed
entity /subsidiary)
Details of the counterparty
entering into the
transaction
Relationship of the counterparty
Name
Name
Type of related party
Details of other related
transaction
party transaction
Value of the related party
Remarks on approval by
transaction as approved
audit committee
by the audit committee
Value of the related party
Date of Audit Committee
Value of transaction
transaction ratified by the
Meeting where the
during the reporting
audit committee
ratification was approved
period
In case monies are due to either party as a result of
In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or
the transaction
investments
Nature of indebtedness
with the listed entity or its
Opening balance
Closing balance
subsidiary
ICICI Life Insurance
Prudential Technology and Promoter Group
Company Limited
Services India Private
Any other transaction
Premium Income
323012.7 Within Omnibus Limit
Fellow subsidiary
Any other transaction
Premium Income
Fellow subsidiary
Any other transaction
Benefits paid
Fellow subsidiary
Any other transaction
Within Omnibus Limit
186.69
Fellow subsidiary
Any other transaction
Premium Expenses
Within Omnibus Limit
-1660.25
Fellow subsidiary
Any other transaction
Security Deposit
Within Omnibus Limit
0.00
Fellow subsidiary
Investment
500000 extended limit approved
Fellow subsidiary
Investment
500000 extended limit approved
Cost
indebtedness
any other etc.)
NA
Details of the loans, inter-corporate deposits, advances or investments
Purpose for which the funds
Nature (loan/ advance/
Details of other
(loan/ issuance of debt/
Tenure
intercorporate deposit/
Interest Rate (%)
Tenure
Secured/ unsecured
investment)
NA
NA
NA
will be utilised by the
ultimate recipient of funds
Notes
(endusage)
3.40
-5.31
-33.68 NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
323012.7 Within Omnibus Limit
702.90
-40.08
-45.85 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
-610.83
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
891.79
1161.03 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
-186.69
-186.69 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
-7527.08
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
2363.15
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Limited
ICICI Life Insurance
ICICI Lombard General
Company Limited
Insurance Company
Limited
ICICI Life Insurance
ICICI Lombard General
Company Limited
Insurance Company
Limited
ICICI Life Insurance
ICICI Lombard General
Company Limited
Insurance Company
Limited
ICICI Life Insurance
Company Limited
ICICI Lombard General
Insurance Company
Limited
ICICI Life Insurance
ICICI Lombard General
Company Limited
Insurance Company
Limited
ICICI Life Insurance
Company Limited
ICICI Lombard General
Insurance Company
by Shareholders
Limited
ICICI Life Insurance
ICICI Lombard General
Company Limited
Insurance Company
by Shareholders
Limited
ICICI Life Insurance
Company Limited
ICICI Lombard General
Fellow subsidiary
Investment
Fellow subsidiary
Dividend received
extended limit approved
Fellow subsidiary
Any other transaction
Premium Income
Fellow subsidiary
Any other transaction
Benefits paid
Fellow subsidiary
Any other transaction
Fellow subsidiary
Any other transaction
Fellow subsidiary
Any other transaction
Insurance Company
0.00
2515.45
10659.17 NA
NA
NA
NA
Investment
NA
NA
NA
Investement Purpose
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
13.74
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
323012.7 Within Omnibus Limit
13.12
-1.77
-1.88 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
-1.11
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
38.54
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
83.71
70.37
36.10 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Within Omnibus Limit
40.93
38.07
23.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
323012.7 Within Omnibus Limit
2524.20
-52.08
-20.90 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
by Shareholders
Limited
ICICI Life Insurance
ICICI Lombard General
Company Limited
Insurance Company
Limited
ICICI Life Insurance
ICICI Pension Fund
Company Limited
Management Limited
ICICI Life Insurance
ICICI Pension Fund
Company Limited
Management Limited
ICICI Life Insurance
ICICI Pension Fund
Company Limited
Management Limited
ICICI Life Insurance
ICICI Pension Fund
Company Limited
Management Limited
ICICI Life Insurance
ICICI Pension Fund
Company Limited
Management Limited
cost
- Employees'
remuneration and welfare
benefits
ICICI Life Insurance
ICICI Prudential Life
Entities over which control is
Company Limited
Insurance Company
exercised
Any other transaction
Premium Income
Any other transaction
Benefits paid
Within Omnibus Limit
-1585.92
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Any other transaction
Contribution to trust
Within Omnibus Limit
-2344.21
-1069.74
-928.57 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Any other transaction
Premium Income
323012.7 Within Omnibus Limit
47.17
-8.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Any other transaction
Benefits paid
Within Omnibus Limit
-54.47
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Any other transaction
Contribution to trust
Within Omnibus Limit
-46.77
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Any other transaction
Contribution to trust
323012.7 Within Omnibus Limit
-2083.73
-685.83
-1138.94 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Any other transaction
Premium Income
323012.7 Within Omnibus Limit
187.69
-1.56
-5.67 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Any other transaction
Contribution to trust
Within Omnibus Limit
-225.59
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
-0.72
-4.78
-5.63 NA
Limited Employees' Group
Gratuity Cum Life
Insurance Scheme
ICICI Life Insurance
ICICI Prudential Life
Entities over which control is
Company Limited
Insurance Company
exercised
Limited Employees' Group
Gratuity Cum Life
Insurance Scheme
ICICI Life Insurance
ICICI Prudential Life
Entities over which control is
Company Limited
Insurance Company
exercised
Limited Employees' Group
Gratuity Cum Life
Insurance Scheme
ICICI Life Insurance
ICICI Prudential Life
Entities over which control is
Company Limited
Insurance Company
exercised
Limited Superannuation
Scheme
ICICI Life Insurance
ICICI Prudential Life
Entities over which control is
Company Limited
Insurance Company
exercised
Limited Superannuation
Scheme
ICICI Life Insurance
ICICI Prudential Life
Entities over which control is
Company Limited
Insurance Company
exercised
Limited Superannuation
Scheme
ICICI Life Insurance
Company Limited
ICICI Prudential Life
Entities over which control is
Insurance Company
exercised
Limited Employees'
Provident Fund
ICICI Life Insurance
ICICI Prudential Life
Entities over which control is
Company Limited
Insurance Advisor Benefit
exercised
Trust
ICICI Life Insurance
ICICI Prudential Life
Entities over which control is
Company Limited
Insurance Advisor Benefit
exercised
Trust
ICICI Life Insurance
ICICI Foundation for
Entities controlled by holding
Company Limited
Inclusive Growth
company
ICICI Life Insurance
Any other transaction
Premium Income
323012.7 Within Omnibus Limit
Autobotz Labs Private
Related entity of relative of Vibha Any other transaction
Company Limited
Limited (Peppermint)
Paul Rishi
ICICI Life Insurance
Suresh Vaswani
Non-Executive Director,
Company Limited
ICICI Life Insurance
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Premium Income
323012.7 Within Omnibus Limit
0.25
0.00
0.64 NA
NA
NA
NA
NA
NA
NA
NA
NA
Omnibus approval limit taken is applicable at entitiy level.
Any other transaction
Premium Income
10000 Within Omnibus Limit
0.24
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Independent Director
Arun Bagchi
Relative of Anup Bagchi
Any other transaction
Premium Income
10000 Within Omnibus Limit
2.50
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
Shishir Bagchi
Relative of Anup Bagchi
Any other transaction
Benefits paid
10000 Within Omnibus Limit
2.90
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Managing Director and CEO of
Any other transaction
Benefits paid
10000 Within Omnibus Limit
2.71
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Any other transaction
Premium Income
10000 Within Omnibus Limit
0.71
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Company Limited
ICICI Life Insurance
Company Limited
ICICI Life Insurance
Sandeep Bakhshi
Company Limited
ICICI Life Insurance
ICICI Bank Limited
Rakesh Jha
Company Limited
ICICI Life Insurance
Limited
Ajay Gupta
Any other transaction
Premium Income
10000 Within Omnibus Limit
3.10
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
Aparna Gupta
Relative of Ajay Gupta
Any other transaction
Premium Income
10000 Within Omnibus Limit
50.00
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
Dhiren Salian
Chief Financial Officer
Any other transaction
Premium Income
10000 Within Omnibus Limit
8.58
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Akshatha D Salian
Relative of Dhiren Salian
Any other transaction
Premium Income
10000 Within Omnibus Limit
0.62
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Sachin Salian
Relative of Dhiren Salian
Any other transaction
Premium Income
10000 Within Omnibus Limit
Souvik Jash
Appointed Actuary
Any other transaction
Premium Income
10000 Within Omnibus Limit
Company Limited
ICICI Life Insurance
Executive Director of ICICI Bank
Executive Director of ICICI Bank
Limited
NA
Company Limited
ICICI Life Insurance
Company Limited
ICICI Life Insurance
Company Limited
ICICI Life Insurance
0.29
0.00
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
0.00 NA
NA
NA
NA
NA
NA
NA
NA
NA
Company Limited
ICICI Life Insurance
12.00
0.00
-130,540.87
98,964.55
Company Limited
Total value of transaction during the reporting period
50,698.49
Notes:
- The details in this format are required to be provided for all transactions undertaken during the reporting period. However, opening and closing balances, including commitments,
to be disclosed for existing related party transactions even if there is no new related party transaction during the reporting period.
- Where a transaction is undertaken between members of the consolidated entity (between the listed entity and its subsidiary or between subsidiaries), it may be reported once.
- Listed banks shall not be required to provide the disclosures with respect to related party transactions involving loans, inter-corporate deposits, advances or investments made or given by the listed banks.
- For companies with financial year ending March 31, this information has to be provided for six months ended September 30 and six months ended March 31.
Companies with financial years ending in other months, the six months period shall apply accordingly.
- Each type of related party transaction (for e.g. sale of goods/services, purchase of goods/services or whether it involves a loan, inter-corporate deposit, advance or investment) with a single party shall be disclosed separately and there should be no clubbing or netting of transactions of same type.
However, transactions with the same counterparty of the same type may be aggregated for the reporting period. For instance, sale transactions with the same party may be aggregated for the reporting period and purchase transactions may also be disclosed in a similar manner. There should be no netting off for sale and purchase transactions. Similarly, loans advanced to and received from the same counterparty should be disclosed separately, without any netting off.
- In case of a multi-year related party transaction:
a. The aggregate value of such related party transaction as approved by the audit committee shall be disclosed in the column “Value of the related party transaction as approved by the audit committee”.
b. The value of the related party transaction ratified by the audit committee shall be disclosed in the column “Value of the related party transaction ratified by the audit committee”.
c. The value of the related party transaction undertaken in the reporting period shall be reported in the column “Value of related party transaction during the reporting period”.
- "Cost" refers to the cost of borrowed funds for the listed entity. 8. Transactions such as acceptance of fixed deposits by banks/NBFCs, undertaken with related parties, at the terms uniformly applicable /offered to all shareholders/ public shall also be reported.
- PAN will not be displayed on the website of the stock echange(s)